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STUDIES ON THE ISOLATION AND PARTIAL CHARACTERIZATION OF 
APOLIPOPROTEIN C FROM HUMAN PLASMA AND CHYLE
CHAPTER I 
INTRODUCTION
Human plasma lipoproteins have been under investigation for sev- 
3ral decades. These lipid-protein complexes have been separated by sev­
eral methods into two major groups which have been designated a^-llpopro- 
tein and Bj-lipoprotein (the nomenclature of lipoproteins is presented 
in the Appendix) based on their electrophoretic mobility in the free- 
boundary electrophoretic system (1). The protein moieties of these two 
lipoproteins were designated apolipoprotein A (ApoA) and apolipoprotein 
B (ApoB) (2), respectively.
The purpose of this study was to further characterize a third 
apolipoprotein, apolipoprotein C (ApoC), which was originally isolated 
from the very low-density lipoproteins (VLDL) of hypertriglyceridemic 
subjects (3). In order to facilitate this study, several methods were 
developed to isolate both partially delipidized lipoprotein C and apo­
lipoprotein C from plasma and chyle. It was established that ApoC is a 
complex apolipoprotein composed of several polypeptides. The ApoC poly­
peptides were separated and partially characterized. Distribution stud­
ies showed that ApoC occurred in all the major ultracentrifugally defined
lipoprotein classes. From these studies the role of apolipoprotein C in 
the structure and metabolism of lipoproteins will be discussed with par­
ticular emphasis on the very low-density lipoproteins.
CHAPTER II
LITERATURE REVIEW
The concept of lipoproteins has its roots in many early obser­
vations such as those of Hoppe-Seyler (4) who found that plasma lipids 
were incompletely extracted by organic solvents. These findings were 
amplified by the work of Nerking (5) who observed that lipid phosphorous 
and cholesterol ester were co-precipitated with the serum globulin frac­
tion. He also found that some of the lipids were extractable with di­
ethyl ether only after proteolytic degradation of the globulin fraction. 
From these observations Nerking postulated the existence of a lipid- 
protein complex. Extension of these observations by several investiga­
tors (6, 7, 8) demonstrated that these lipid-protein complexes were pres­
ent primarily in the euglobulin fraction.
The concept of lipoproteins was put on a firm experimental basis 
in 1929 by Macheboeuf's (9) isolation from horse serum of a lipid-protein 
fraction of constant composition. Reproducible amounts of cholesterol 
ester, lipid-phosphorous, and protein were characteristic of this mate­
rial. It was demonstrated that the protein portion was not albumin or 
any of the known globulins and therefore represented a specific lipid- 
binding protein (10).
During the next two decades it was established that all plasma
4lipids, excluding unesterified fatty acids, were associated with speci­
fic lipoproteins. On free-boundary electrophoresis the majority of lip­
ids were associated with proteins that had either a^- or 6i-globulin mo­
bility (1). The lipoproteins with a%- and Bj-mobility have been desig­
nated ai-lipoproteins (aj-LP) and B^-lipoproteins (Pj-LP), respectively.
Fractionation of human plasma in ethanol-water mixtures at low 
temperatures led to the first large scale isolation of two types of lipo­
proteins (11, 12). Gurd e^ (13) showed that these two lipoprotein 
fractions differed in their lipid composition, molecular size and shape, 
and solubility properties. These two lipoproteins exhibited electropho­
retic mobilities corresponding to those of uj-LP and Bi-LP.
Plasma lipoproteins are characterized by low hydrated densities 
which are due to the relatively low densities of the lipid portions of 
the lipoprotein molecules (14, 15). The anomalous schileren patterns ob­
served by McFarlane (16) could be explained by the presence of lipopro­
teins. In fact, by adjusting the density of the suspending media, 
Pedersen (17) isolated ultracentrifugally a lipoprotein that had the 
electrophoretic mobility of 6i”LP. On the basis of these findings.
Gofman e^ al. (18) introduced an important ultracentrifugal technique 
which was soon refined into a method for the quantitative isolation and 
determination of plasma lipoproteins. This technique involved the flota­
tion of lipoproteins followed by analytical ultracentrifugation at a sol­
vent density of 1.063 g/ml at 26°C. The floating lipoprotein fraction 
was characterized by a 6i”globulin mobility and a flotation coefficient 
(Sg.) greater than zero (19, 20).
Refinements of the ultracentrifugal method have led to the
5separation of lipoproteins into the following major density classes 
(21-23): (1) chylomicrons (S^ ■ 400), (2) very low-density lipoproteins 
(VLDL, d ' 1.00& g/ml, S^ . 20-400), (3) low-density lipoproteins (LDL, d 
1.006-1.063 g/ml, 0-20), (4) high-denslty lipoproteins (HDL, d 1.063- 
1.21 g/ml), and (5) very high-denslty lipoproteins (VHDL, d > 1.21 g/ml). 
Oncley and coworkers (24) and Ewing ejt (25) have suggested, on the 
basis of studies on macromolecular distributions, that at least the first 
four major classes represent polydisperse systems, heterogeneous with 
respect to both particle size and hydrated density. The above separation 
and classification system has made ultracentrifugation the most widely 
used method of isolating lipoproteins for both analytical and preparative 
purposes. Although chylomicrons are considered particles of dietary ori­
gin, they have been detected not only in individuals following an over­
night fast but also in some persons maintained on a fat-free diet (26). 
Unfortunately, there has been no method for differential separation of 
endogeneous and exogeneous particles; for that reason the flotation co­
efficient boundary > 400 has remained rather arbitrary.
In general the VLDL, LDL, and HDL corresponded electrophoretic- 
ally to a 2“LP, Bj-LP, and a^-LP, respectively, on various supporting 
media at alkaline pH (26-28). The mobility of chylomicrons varied de­
pending on the media utilized (27, 29, 30).
Another method that was applicable on a preparative scale was the 
precipitation of lipoproteins with various polyanionic agents. The most 
commonly used polyanions have been the sulfated polysaccharides in the 
presence of a divalent cation. Some of the sulfated polysaccharides that 
have been utilized are heparin (31), sulfated amylopectin (31), dextran
6sulfate (32), mepesulfate (3J), and others (34). Serun has been the 
usual starting material because fibrinogen is also precipitated if plasma 
is uLiliiC-d (31, 34). The lipoprotein complexes with heparin, dextran 
sulfate, or mepesulfate can be dissociated by addition of a solution of 
high ionic strength, increasing the pH to greater than 9, addition of 
chelating agents, or by selectively precipitating out the sulfated poly­
saccharides as a Ba^, S r ^  or protamine salt complex (34). The addition 
of polysaccharides resulted in a specific precipitation of B-LP with a 
simultaneous flocculation of the rather poorly defined chylomicrons 
(32-34). Interaction of sulfated polysaccharides with B-LP was primarily 
electrostatic (35-37). It seems that the free amino groups (36) or nitro­
genous bases of the phospholipids (37) represented the functional group 
on B-LP mainly responsible for this interaction. Another polymer, poly­
vinylpyrrolidone, has been utilized to differentiate and selectively floc­
culate chylomicrons (38, 39).
Several methods have been developed to precipitate %i-LP. A 
sequential addition of sucrose, heparin, magnesium, and a low molecular 
weight dextran sulfate resulted first in the precipitation of Bi-LP fol­
lowed by the precipitation of uj-LP (40). A more recent procedure uti­
lized phosphotungstate for the precipitation of Bi-LP and aj-LP in a 
stepwise fashion (41).
Several chromatographic procedures have been utilized for puri­
fication or separation of lipoproteins from various density classes. 
Hydroxyapatite has been used either to isolate Bi-LP from serum in a rel­
atively pure form (42) or to separate the B-LP from a-LP (43-45). Al­
though cross-linked dextrans, particularly Sephadex G-200, fractionated
7serum lipoproteins into #-LP and a-LP (46), there was no separation of 
the larger molecules such as chylomicrons and VLDL from g-LP. Recently, 
with the availability of commercial agarose preparations, several authors 
have utilized 2-6% agarose gels for fractionating plasma lipoproteins 
(47, 48). Due to the larger pore size, 2-6% agarose gels have been shown 
to be satisfactory for fractionating lipoproteins on the basis of size 
with the 2% agarose gel being more satisfactory for the separation of the 
chylomicrons and VLDL (49).
Although very useful for analytical and clinical studies, several 
other separation techniques have not been utilized on a preparative scale 
because of limitations in the sample size and other technical difficul­
ties, especially when compared with preparative ultracentrifugation or 
the precipitation methods. Zone electrophoresis has been utilized with 
a wide assortment of media to identify lipoproteins, but elution is 
rather tedious, and sample size is small for preparative purposes. Paper 
electrophoresis employing buffer containing albumin (50) has become a 
major tool for differentiating various types of hyperlipidemias (51).
With the development of zonal rotors it has been possible to fractionate 
VLDL and LDL, but not HDL, from whole serum in a density gradient; unfor­
tunately, the lipoprotein fractions are greatly diluted (52).
Discontinuous electrophoresis on polyacrylamide gels as de­
scribed by Davis (53) has become a potentially powerful method for both 
diagnostic and clinical screening of various lipid transport disorders 
(54, 55). Also, analytical electrofocusing of serum after prior stain­
ing of lipoproteins with Sudan Black has been shown to separate lipopro­
teins into several components (56).
8Chemistry of Lipoproteins 
The chemistry of lipoproteins has been based principally on 
the study of substances isolated by ultracentrifugation techniques. The 
lipid composition of various plasma lipoprotein density classes is shown 
in Table 1. As the density of the lipoprotein class increases (chylo­
microns to VHDL), the neutral lipid content decreases and the protein 
content increases. It has been reported that various density classes 
contain, in addition to triglycerides, esterified and unesterified cho­
lesterol and phospholipids, also minor components such as glycolipids, 
gangliosides and hydrocarbons (57-60). The phosphatide composition of 
the various density classes is summarized in Table 2. Carbohydrate anal­
yses of the delipidated LDL and HDL have indicated the presence of 4-5% 
and 1.5-3% carbohydrate in the respective apolipoproteins (62-65). Prin­
cipal reported sugars are hexoses, N-acetylneuraminic acid (NANA), glu­
cosamine, and traces of fucose (62-65).
The structure of various lipoprotein density classes has been 
studied by several different approaches. Extraction of lipoproteins 
under appropriate conditions led to the removal of all the lipids except 
for small amounts of firmly bound long chain fatty acids (66). From this 
and similar studies, it has been concluded that the forces binding the 
lipid to the protein are non-covalent in nature.
Electronmicrographs have shown that chylomicrons, VLDL, LDL and 
HDL are spherical in nature (67-69). Recent results with negative stain­
ing of HDL have indicated a subunit structure of 4-5 subunits with some 
indication of aggregation (70). Similarly, it has been concluded from 
the results of electron microscopy that LDL consists of 20 subunits (71).
TABLE 1
PERCENT COMPOSITION OF THE MAJOR PLASMA LIPOPROTEIN DENSITY CLASSES
Density
Protein Phospholipid
Cholesterol
Triglyceride NEFA^
Class Free Ester
Chylomicrons^ 2.0 7.0 2.0 5.0 84.0 -
VLDL^ 8.0 18.0 7.0 12.0 50.0 2.0
LDL*' 21.0 22.0 8.0 37.0 11.0 1.0
HDL*' 50.0 22.0 3.0 14.0 8.0 3.0
VHDL^c 62.4 28.0 0.3 3.2 4.6 0.6
VHDLg^ 98.45 0.83 0.002 0.05 0.05 0.6
Non-esterifled fatty acids 
^Ref. 14
Ref. 23
TABLE 2
PERCENT COMPOSITION OF PHOSPHOLIPIDS OF SERUM LIPOPROTEIN DENSITY CLASSES
Chylo-g
microns
VLDL^
Sf
20-400
LDlf
Sf
0-20
HDLg^ HDLgb > 1.21^
Sphingomyelin 18.7
(12-24)
14.8
(14.0-17.0)
25.9
(21.3-29.1)
14.5
(10.8-16.7)
9.2 
( 5.2-11.9)
5.7 
( 3.9- 8.9)
Phosphatidylcholine 72
(66-79)
59.7
(48.7-78.5)
63.7
(34.6-73.7)
73.8
(66.1-82.5)
77.1
(70.9-84.2)
47.4
(37.4-54.1)
Lysophatidylcholine 4
( 3-5 )
5.0 
( 2.7- 9.0)
2.7 
( 1.8- 3.8)
2.0 
( 1.0- 3.6)
5.4 
( 3,8- 7.6)
34.5
(15.4-44.5)
Phosphatidylinositol - 3.6 
( 2.5- 5.4)
1.6 
( 1.1- 2.8)
2.4 
( 1.5- 3.0)
2.4 
( 1.6- 3.1)
1.9 
( 1.1- 3.7)
Phosphatidylserine - 1.5 
( 1.3- 1.7)
0.8 
( 0.2- 1.4)
0.9 
( 0.3- 1.2)
0.6 
( 0.5- 0.8)
0.5 
( 0.3- 0.8)
PhosphaCidylethanolamine 6 4.6 
( 3.0- 6.4)
2.2 
( 1.1- 3.9)
3.3 
( 1.9- 4.0)
2.5 
( 1.8- 3.0)
4.2 
( 2.6- 5.5)
Polyglycerophosphatides — 7.6 
( 5.0- 9.6)
2.0 
( 1.2- 3.3)
2.2 
( 1.5- 2.9)
2.0 
( 1.5- 3.0)
3.4 
( 2.4- 5.8)
^Averaged values. Ref. 61- ^Ref. 59.
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The ■ 0 lipoproteins are thou};ht to be raicellar in nature 
(72, 73) in that they contain a neutral lipid micellar core composed of 
triglycerides and cholesterol ester surrounded by an outer layer or "mem­
brane" composed of phospholipid, protein, and unesterified cholesterol 
(3). The presence of a portion of the protein on the surface of the LDL 
and VLDL has been confirmed by N-terminal analysis (74) and chemical mod­
ification of free amino groups of lysine (> 90%) (75, 76) of the intact 
lipoprotein. Phospholipase A and C treatment of > 0 has confirmed the 
presence of phospholipids at the surface of these lipoproteins (77, 78).
From infrared and circular dichroic spectral studies it has 
been concluded that LDL contains a significant amount of anti-parallel 
chain 6-scructure in addition to random structure and probably some a- 
helix structure (79), wh^le HDL is relatively richer in a-helix (79, 80). 
It has been inferred from nuclear magnetic resonances studies that both 
LDL and HDL exist at least in part as micellar structures (81). The mo­
lecular weights and diameters of the various lipoprotein density classes 
are shown in Table 3.
Studies on the immunochemical properties of the lipoproteins 
have shown that 6-LP and a-LP are antigenically different (83-85). How­
ever, there has been a great deal of controversy in the literature con­
cerning the number of antigenic components present in the various density 
classes. Gitlin (86) reported that the g-lipoproteln fraction was com­
posed of a number of lipoproteins differing markedly in their immunochem­
ical characteristics. Utilizing agar diffusion as described by Oudin 
(87), Aladjem e^ (83) observed that lipoproteins with = 6 and 
= 13 gave up to eight precipitin lines with antibodies to LDL after
12
TABLE 3
MOLECULAR WEIGHTS AND DIAMETERS OF VARIOUS 
LIPOPROTEIN DENSITY CLASSES^
Lipoprotein
properties
Chylomicrons VLDL LDL HDL2 HDL^ VHDL
Diameter
(mu) 120-1,100 21-76 19 10.3
7.9 7.4
Molecular
weight
X 10-6
500-430,000 3-128 2.2 0.38 .18 .15
®Ref. 82.
13
five days of diffusion. They did not observe this phenomenon in the re­
action of HDLg and IIDL^ with the corresponding antisera. It was concluded 
from these experiments that the lipoproteins were heterogeneous by this 
criterion and non-identical to the other serum proteins.
Brinner al• (88) observed, using a hemagglutination tech­
nique, that the 3-9 lipoprotein fraction contained one or more anti­
genic components in addition to the one common to the 10-400 range.
The finding of two antigenic determinants for 0-20 (6-LP) has been 
recently reported (89, 90). However, other investigators have reported 
the antigenic homogeneity of LDL. Levine and coworkers (85), utilizing 
techniques similar to those applied by the above investigators, found 
evidence for antigenic homogeneity by complement fixation, single diffu­
sion, and double diffusion in agar. Similarly, Walton and Darke (91) 
concluded from double diffusion in agar and a tanned sheep-cell agglu­
tination technique that there was complete antigenic homogeneity through­
out the density range (8^ > 0) investigated. By immunoelectrophoresis 
and double-diffusion, Scanu (84) drew the conclusion that the LDL
or 6-LP fraction was homogeneous. These conflicting views on the anti­
genic homogeneity or heterogeneity of LDL could be explained either by 
the differences in methodology, antibody titer, and isolation procedures 
for lipoproteins or by the presence of contaminating serum proteins such 
as enzymes (92). Although most investigators considered the presence of 
a single antigenic component (84, 91), recent results again suggested the 
probable occurrence of two non-identical antigenic components (90, 93).
In cases of obstructive jaundice an abnormal lipoprotein was 
reported in the LDL (94, 95). This abnormal lipoprotein (LP-X) was sep­
14
arated from LF-A and LP-B present in the LDL and shown to be immunochem- 
ically different from both LP-A and LP-B (96).
Two different polymorphic groups were identified in 6-lipopro­
teins, the Ag- and Lp-groups. The Ag-groups represented polymorphisms 
that were detectable by precipitation with isoimmune sera (97), and the 
Lp-groups were demonstrable by use of precipitating heteroimmune sera 
from rabbits (98). Recently, the 6-LP carrying the LP-(a^) component 
was isolated from HDLg by two different procedures (60, 44). It was also 
reported that the protein moiety of 6-LP (ApoB) was present in the HDL 
infranate obtained after centrifugation (99), but this finding has not 
been confirmed.
Immunochemical studies on the protein moiety of 6-LP (ApoB) were 
hampered by the fact that ApoB was insoluble in aqueous buffers (2, 85, 
100). However, either by various chemical modifications (76, 80, 101) 
or by the use of sodium dodecyl (102) or decyl sulfate (103), a soluble 
ApoB was obtained. With succinylated ApoB, partial identity or no reac­
tion was observed with anti-serum prepared against 6-LP (76, 101). All 
other chemical derivatives of both the lipoprotein and apolipoprotein 
showed no identity with 6-LP; however, ApoB solubilized with sodium decyl 
sulfate gave an identity reaction with 6-LP when tested with antibodies 
to ApoB (80, 103).
The immunochemical components of a-LP have also been studied, 
with some controversy over the number of antigenic components present. 
Both HDLg and the apolipoprotein exhibited two characteristic precipitin 
lines on the immunodiffusion pattern and two to three precipitin arcs 
upon immunoelectrophoresis with antibodies to either HDL^ or to the cor­
15
responding apolipoprotein (23, 104). The antigenic forms of HDL were 
interpreted as either various forms of partially delipLdized lipoproteins 
or molecular aggregates formed upon storage (26, 106). The principal 
apolipoprotein of HDL, apolipoprotein A, was detected also in the chylo­
microns, VLDL, and LDL (3, 90, 107, 108).
Work on the immunochemical components of chylomicrons was ham­
pered by the small amount of protein present and also by the large dia­
meter of chylomicrons which might have prevented migration into the sup­
port media used for immunochemical studies (48). Both apolipoproteins A 
and B were identified immunochemically in the chylomicrons of both serum 
and chyle (107, 108). The presence of apolipoprotein A was supported by 
chemical evidence such as N-terminal amino acid and peptide fingerprint 
analyses of the protein moieties of chylomicrons and high density lipo­
proteins (109, 110).
The VLDL with U 2 mobility (28, 111) was reported to contain only 
6-LP immunochemically (84, 91). However, the disruption of the VLDL 
structure with diethyl ether revealed the presence of a second antigenic 
component, apolipoprotein A (111); dissociation of the heparin precipi­
tate of VLDL also revealed two components which were identified immuno­
chemically as a-LP and 6-LP (112). Gustafson ejt al. (3) reported that 
VLDL of hypertriglycerideraic subjects contained an additional antigenic 
component besides those corresponding to a-LP and g-LP.
Until recently, it was accepted by most investigators that HDL 
had one lipoprotein family, the protein moiety of which was designated 
apolipoprotein A. This was also the case for LDL, the protein moiety of 
which was designated apolipoprotein B. The protein moiety of VLDL was
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thought to be identical with apolipoprotein B with some disagreement over 
the presence of apolipoprotein A. The presence of other immunochemical 
components in the various density classes besides those mentioned above 
was thought to represent contamination by other density classes or other 
serum proteins (104).
Surprisingly, the immunochemical heterogeneity of the various 
densities was not correlated with the terminal amino acid analyses.
Table 4 shows the reported terminal amino acids for the various lipopro­
tein density classes. Terminal amino acid analyses of VLDL indicated 
glutamic acid, serine, threonine, and aspartic acid as the N-terminal 
and serine and alanine as C-terminal amino acids. The N-terminal analy­
sis of chylomicrons indicated the same terminal amino acids as VLDL, but 
glutamic acid was not identified. The LDL and HDL were also heterogene­
ous with respect to both the N- and carboxyl terminal amino acids. Glu­
tamic acid and aspartic acid were considered the N-terminal amino acids 
for apolipoprotein B and apolipoprotein A, respectively. Serine has been 
reported as the carboxyl terminal amino acid for ApoB and threonine for 
ApoA.
Apolipoproteins
Apolipoproteins of the Very Low- 
Density Lipoproteins
Results of N-terminal analyses and the immunochemical findings 
suggested that VLDL and chylomicrons were composed of as many as four 
proteins, two of which were positively identified as ApoA and ApoB. Sim­
ilar data from studies with LDL and HDL suggested that the principal apo­
lipoproteins of these density classes were ApoB and ApoA, respectively.
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TABLE 4
TERMINAL AMINO ACIDS OF LIPOPROTEIN DENSITY CLASSES
Amino acids
Aspartic
acid
Glutamic
acid
Serine Threonine
N-terminal^
Chylomicrons^ + + - + + +
VLDL*'^ + + + + + +
LDL^'b'C Trace + + + + + +
HDL*'b'C + + + + + + +
Threonine Serine Alanine Glycine
C-terminal*"
Sg 20-60 - + + -
Sf 6-8 + + + + +
+
HDL2 + + + + + +
HDL. + + + + +
3
Ref. 109.
Ref. 74.
Ref. 113.
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Due to its apparent protein heterogeneity, the VLDL represented the most 
likely candidate as a source for the Isolation and identification of un­
known apolipoproteins.
Gustafson e£ al. (114) developed a method for the fractionation 
of VLDL into five subfractions by sequential angle-head ultracentrifuga­
tion but concluded from the N-terminal analyses and immunological find­
ings that none of the subfractions consisted of a distinct apolipopro­
tein. The alternative approach consisted of delipidizing the VLDL and 
fractionating it into its various apolipoproteins. In order to improve 
the recovery of soluble proteins, a partial delipidization procedure 
(115, 116) was developed which consisted of lyophilizing the VLDL in the 
presence of insoluble potato starch followed by extraction of the neutral 
lipids with n-heptane at -10“C. The recovery of phospholipid-protein 
residues soluble in aqueous buffers is presented in Table 5. The phos­
pholipid-protein residue of LDL was sparingly soluble and that of HDL 
completely soluble; the corresponding residues of chylomicrons and VLDL 
(Sg > 400 and 20-400) exhibited intermediate solubility.
Fractionation of the VLDL phospholipid-protein residues (117,
3) on Pevikon block electrophoresis resulted in separation of two zones. 
The slower moving component was shown to be immunologically identical to 
the antigenic component of 6-LP by several different criteria, whereas 
the second zone consisted of two partially delipidized lipoproteins which 
were further fractionated by preparative ultracentrifugation at d = 1.105 
g/ml for 44 hours at 105,000 g. In this manner the two partially delip­
idized lipoproteins were separated with the infranate containing protein 
moiety which was identical to the apolipoprotein of a-LP (Table 6). The
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TABLE 5
PARTIAL DELIPIDIZATION STUDIES ON LIPOPROTEIN 
DENSITY CLASSES®
Lipoprotein 
Density Class
Phospholipid/Protein Ratio 
Lipoprotein Residue
Recovery of 
Soluble Protein
%
Chylomicrons Sg > 400 3.5 1.3 93
VLDL Sg 20-400 1.8 1.2 60
LDL 0.8 0.7 10
HDL 0.9 0.8 100
Ref. 116.
TABLE 6
COMPARISON OF PARTIALLY DELIPIDIZED LP-A, LP--B AND LP-C*
Lipoprotein
Fraction
Electrophoretic
Fraction s°20,w
Hydrated
Density
Precipitin Reaction 
with
A-a-LP A-6-LP AWS
N-
terminal
Peptide
HDL (LP-A) N.D.^ 4.3 1.17 + + Asp
LDL (LP-B) N.D.^ 14.5 1.18 + + Glu
VLDL (LP-A) II 4.5 1.17 + — + Asp Identical to a-LP
VLDL (LP-B) I 14.0 1.13 + + Glu Identical to 0-LP
VLDL (LP-C) II 6.9 1.09 + Ser
and
Thr
Different from 
a- and 6-LP
o
a
Réf. 3.
Not determined.
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phospliolipid-protein residue in the supernate was immunologically differ­
ent from both a-LP or P-LP, and the protein moiety of this unknown lipo­
protein was designated apolipoprotein C (ApoC). The three phospholipid- 
protein residues isolated from the hyperlipemia VLDL were characterized 
by their immunochemical behavior, N-terminal amino acid analysis, hy­
drated densities, peptide patterns of tryptic and peptic hydrolysates, 
sedimentation and diffusion coefficients, and quantitative composition 
of the individual phospholipids (3). These results (Table 6) clearly in­
dicated that the VLDL of hyperlipemia subjects was composed of three 
phospholipid-protein residues, two of which had apolipoproteins A and B 
as their protein moieties; the third protein moiety, designated as apo­
lipoprotein C, consisted either of two non-identical peptides or repre­
sented actually two distinct apolipoproteins (3).
The molecular weight of the phospholipid-apolipoprotein C resi­
due was found to be 834,000 by sedimentation-diffusion data (15). Pre­
liminary results on the percent distribution of three phospholipid-protein 
residues in VLDL (A, B and C) indicated some variation in the quantities 
of A and C in two types of hypertriglyceridemias; the relative contents 
of ApoA and ApoC varied from 4% to 33% and 9% to 48%, respectively (3).
Although the finding of a third apolipoprotein (ApoC) was ac­
cepted with some skepticism, recent studies confirmed its occurrence in 
normal and hypertriglyceridemia plasma (118-122). Brown e^ aJ^ . (1J8) 
found that VLDL partially delipidized with n-heptane (116) gave three 
precipitin lines with antibodies to VLDL, two of which were identical to 
those obtained with specific antisera to LDL and HDL; the third line was 
a unique reaction obtained only with antibodies to VLDL. The phospho-
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lipid-protein residues obtained by partial delipidization of VLDL were 
fractionated by Pevikon block electrophoresis into two zones. In con­
trast to original finding by Gustafson al. (117), fractions from both 
zones gave a unique reaction with antibodies to VLDL. The second zone 
was centrifuged as described by Gustafson et (3), but no separation 
of the 4S and 7S residues was achieved. Since another attempt to sepa­
rate the ApoA- from ApoC-phospholipid residues by Sepharose 4B column 
chromatography failed. Brown e^ a^. (118) concluded that the phospholipid- 
protein residues obtained by partial delipidization of VLDL resulted in 
an aggregate of phospholipid and protein which prevented their further 
purification.
From the above results it was concluded that the fractionation 
of VLDL apolipoproteins might be achieved by column chromatography of 
totally delipidized VLDL (118). The VLDL, totally delipidized with eth- 
anol-ether, was partially soluble in Tris buffer (pH 8.2). Application 
of the soluble portion (30% of the apo-VLDL) to a Sephadex G-lOO column
(115 X 1.2 cm) yielded two peaks. The first peak reacted only with anti­
bodies to HDL and displayed on polyacrylamide gel electrophoresis mobil­
ity similar to that of ApoA; the second peak (82) reacted only with anti­
bodies to VLDL and on immunoelectrophoresis exhibited two precipitin arcs
with «2 and y mobilities. Eighty percent of the soluble apo-VLDL was 
found in the second peak. This peak (82) was then fractionated on DEAE- 
cellulose with a two-stage linear gradient into four peaks designated Dl, 
D2, D3, and D4. The Dl, D3, and D4 peaks were homogeneous on disc gel 
electrophoresis whereas D2 was not. Purification of D2 was achieved by 
utilizing essentially the same procedure as already described (119). The
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totally delipidized VLDL (apo-VLDL) was dissolved (> 90%) in Tris buffer 
containing 0.1 M sodium decyl sulfate and passed over a Sephadex G-150 
column (1.2 x 110 cm) which resolved the material into three peaks 
(S1-S3). The S3 peak was then fractionated on a DEAE-cellulose column 
into 4 peaks, each of which was homogeneous by polyacrylamide gel elec­
trophoresis.
Each peak was characterized by amino acid analysis, N- and C- 
terminal amino acids, disc gel electrophoresis, sedimentation equilibrium 
experiments, sialic acid content, and by immunological properties (118, 
120). These results are summarized in Table 7. Dl and D2 did not re­
lease any amino acids when treated with carboxypeptidase A, but hydra- 
zinolysis revealed valine and glutamic acid, respectively. The amino 
acid compositions and immunochemical identity of D3 and D4 indicated that 
these two polypeptides were identical. However, the greater mobility of 
D4 on the disc gel electrophoresis was explained by the fact that D4 had 
twice as much sialic acid (1.2 moles/mole protein) as D3 (0.6 moles/mole 
protein). Treatment of D3 or D4 with neuraminidase for 24 hours resulted 
in the appearance on polyacrylamide gel of a single band with a mobility 
slower than that of either D3 or D4. From the sialic acid studies it was 
concluded that D3 and D4 are polymorphic polypeptides differing only in 
one mole of sialic acid (120).
Brown e£ (118-120) estimated that the D1-D4 polypeptides 
comprised 35-50% of the protein moiety of VLDL. They confirmed also the 
presence of ApoA and ApoB in the VLDL and reported the presence of D1-D4 
in normal lipemic subjects (119). In commenting upon the relationship of 
D1-D4 polypeptides and apolipoprotein C, these authors suggested that
TABLE 7
CHARACTERISTICS OF POLYPEPTIDES ISOLATED FROM VLDL*
Polypeptide
designation
N-
terminal
C-
terminal
Missing 
amino acid
Molecular
weight
Immuno-
electrophoretic
mobility
Apo-LP-Val (Dl) Threonine Valine Histidine, tyrosine, 
cysteine, cystine
7,000 Y
Apo-LP-Glu (D2) Threonine Glutamic
acid
Histidine, cystine, 
cysteine
10,000 N.D.b
Apo-LP-Ala (D3) Serine Alanine Isoleucine, cystine, 
cysteine
10,000 0(2
Apo-LP-Ala (D4) Serine Alanine Isoleucine, cystine, 
cysteine
10,000 '■'■2
N3
Ref. 120.
Not determined.
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apolipoprotein C probably consisted of a mixture of D1-D4 in combination 
with large amounts of phospholipids. However, Gustafson et. (^) con­
sidered only the protein moiety as apolipoprotein C which upon total 
delipidization of its corresponding phospholipid-protein residue gave 
only serine and threonine as the N-terminal amino acids. The four poly­
peptides isolated by Brown e^ (118) were designated in the following 
manner: apolipoprotein-Val (apo-LP-Val, Dl), apolipoprotein-Glu (apo-
LP-Glu, D2), and apolipoprotein-Ala (apo-LP-Ala, D3 and D4). Unfortu­
nately, these authors have not presented any experimental evidence for 
the existence of lipoproteins with the designated polypeptides as the 
sole protein moieties.
Recently a polypeptide with alanine as the carboxyl terminal 
acid was isolated from both VLDL and HDLg (121). Scanu also reported 
the isolation of a group of polypeptides from HDLg (122) which had cer­
tain characteristics similar to those isolated by Brown et al. (118) .
Results of recent studies indicated that some VLDL polypeptides 
might play a role as the activators of lipoprotein lipase, an enzyme in­
volved in the hydrolysis of plasma triglycerides (123) . It was reported 
that low concentrations of the human polypeptide R-Glu in the presence 
of phospholipids activated lipoprotein lipase isolated from either cows' 
milk (124) or rat adipose tissue (125) . Another polypeptide R-Ala was 
also found to be active to a lesser extent (124-125). The R-Val (apo- 
LP-Val) and the major polypeptides of HDL (R-Gln and R-Thr) were inac­
tive with or without phospholipids (124-125).
ApoA or the HDL Peptides 
Shore and Shore (126) reported the first successful separation
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of two different polypeptide components from any density class or lipo­
protein. Fractionation of totally delipidized HDL^ was achieved by DEAE- 
cellulose column chromatography in the presence of 8 M  urea. Three peaks 
were obtained, the first and second being homogeneous by disc gel elec­
trophoresis, and the third being a mixture of the first two. By carboxy­
peptidase A and/or B studies it was concluded that the carboxyl termin­
al amino acids were glutamine and threonine for the first and second 
peaks, respectively. The results of carboxypeptidase studies were con­
firmed by hydrazinolysis of apo-HDL^. Analysis of the hydrazinolysis
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products revealed threonine (1 mole/50 x 10 g of protein) by amino acid 
analysis while glutamic acid-y-hydrazide was demonstrated by chromatog­
raphy of the di-DNP compound. The two isolated polypeptides had dissim­
ilar mobilities on disc gel electrophoresis with the polypeptide desig­
nated R-Glutamine (R-Gln) moving faster than the polypeptide designated 
R-Threonine (R-Thr).
Subsequent work by the Shores (127) resulted in further charac­
terization of the two non-identical polypeptides of HDL. Determination 
of the molecular weight of R-Gln by sedimentation equilibrium experiments 
in 8 M urea or 6 M guanidine-HCl gave values of 14,300 and 14,900. The 
molecular weight of R-Thr measured by sedimentation equilibrium was 
31,400; it was concluded from the release of threonine by carboxypepti­
dase and the minimum molecular weight calculated from the amino acid com­
position that this value represented a dimer form of R-Thr. The differ­
ences in the amino acid composition further confirmed the non-identity of 
these two polypeptides. Amino acid analysis of R-Glutamine indicated the 
absence of histidine, arginine, cysteine, and tryptophan whereas the
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amino acid composition of R-Threonine revealed only the absence of cyst­
ine, cysteine, and isoleucine. Shore and Shore concluded from this study 
that the two isolated polypeptides were non-identical and that the HDL^ 
lipoprotein molecules probably contain a total of six polypeptide units.
The Shores (121) expanded their work by fractionating totally 
delipidized HDLg and lipoproteins of S^ 4-8 and S^ 20-100 on DEAE-cellu­
lose columns. Carboxypeptidase and hydrazinolysis of these totally de­
lipidized density classes revealed only glutamine, threonine, and alanine 
as the carboxy terminal amino acids. In examining the HDLg, the Shores 
reported the presence of three polypeptides having threonine as the C- 
terminal amino acid. One of these was identical to the R-Thr isolated 
from apo-HDLg (126). This polypeptide was designated R^-Thr, and the 
other two were named Rg-Thr and R^-Thr. The major difference between 
R^-Thr, Rg-Thr, and R^-Thr was the absence of isoleucine from R^-Thr.
R-Ala peptides found in lipoproteins with S^ 20-100 and HDL^ differed in 
the amount of isoleucine present. Another peptide with tryptophan miss­
ing was found in HDLg and S^ 20-100. The Shores concluded (122) that 
R-Ala and a peptide with tryptophan deleted were common to HDL^, HDL^, 
and S^ 20-100. From these data they suggested that there are multiple 
forms of R-Thr and R-Ala peptides which might have some importance in 
lipid binding.
Several other investigators confirmed the Shores' results by 
fractionating HDL into several polypeptide fractions. Rudman e^ (128) 
separated HDL delipidized with acetone-ethanol (1:1, v/v) into three 
peaks on Sephadex G-200 column chromatography equilibrated with 1 N ace­
tic acid. Examination of these fractions by peptide fingerprints, amino
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acid composition, and immunodiffusion suggested the presence of at least 
two non-identical polypeptides. The amino acid composition of these frac­
tions did not agree with the data compiled by the Shores (126) for R-Thr 
and R-Gln. Modification of the delipidization procedure by Rudman and co­
workers (129) led to the introduction of column chromatography on Sephadex 
LH-20 equilibrated with 2-butanol:acetic acidiHgO (4:1:5) to achieve total 
delipidization of HDL. The apolipoprotein eluted from the LH-20 column 
was resolved by column chromatography on Sephadex G-200, as described 
previously (128), into two major peaks and one minor peak (129). The 
major peaks corresponded to R-Thr (peak II) and R-Gln (peak III) by amino 
acid composition and mobility on disc gel electrophoresis. The minor 
peak (peak I), which was eluted before the major peaks, appeared to be an 
aggregate of the second peak (R-Thr). Peak I was greatly increased if 
the second peak was lyophilized and rechromatographed. This observation 
was also supported by the similarity in the amino acid composition be­
tween the first and second peak. Only peak III reacted with antibodies 
to HDL and showed an identity reaction with ApoA. Rudman e^ (129) 
concluded that a-protein (ApoA) consisted of two distinct polypeptides 
which were very similar to those isolated by the Shores (126).
Fractionation of the totally delipidized HDL^ into several com­
ponents by Sephadex gel filtration in the presence of 8 M urea has been 
reported (122). The apo-HDL^ was resolved into five peaks (I-V), two of 
which (III and IV) were similar on the basis of the amino acid composi­
tion and electrophoretic mobility on polyacrylamide gel to those isolated 
by the Shores (126) and Rudman ^  al. (129). The first peak (I) was 
thought to be an aggregate of III and IV. Peak II was omitted from dis-
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cussion because of its variability in occurrence. Peaks III and IV were 
thought to correspond to R-Thr and R-GIn. Fraction V comprised approxi­
mately 5% of the total recovered material and was heterogeneous on disc 
gel electrophoresis. All peaks obtained from column chromatography were 
heterogeneous by the criterion of analytical electrofocusing. The appar­
ent molecular weights determined from a calibrated Sephadex G-200 column 
were 52-55*10^ (I), 25.8-28.0*10^ (III), 16.4-17.6*10^ (IV), and II.2-
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11.8*10 (V). These molecular weights were corroborated by sedimentation
equilibrium experiments and by gel electrophoresis in sodium dodecyl sul­
fate. Double diffusion studies showed that Fraction V reacted with anti­
bodies to apo-HD*.„ but not with antibodies to either Fraction III or 
Fraction IV. Reactions of partial identity between Fractions III and IV 
were obtained with both anti-III and anti-IV, Thus, one could conclude 
that Fractions III and IV had a common antigenic component and that Frac­
tion V was immunochemically free of both Fractions III and IV. Scanu 
et al. concluded from this study that each fraction (III-V) was a dis­
tinct class of polypeptides, each of which was made up of subcomponents. 
However, neither Scanu and coworkers (122) nor Rudman et (129) in­
vestigated the terminal amino acids of the isolated polypeptides.
Investigation of the HDL by Alaupovic £t al. (130) was approached 
in a different manner. The HDL was not totally delipidized but was 
first fractionated in its intact form into three lipoprotein families: 
lipoprotein A, LP-A; lipoprotein B, LP-B; and lipoprotein C, LP-C (2).
This was done to minimize complications arising from contamination of 
ApoA by the other apolipoproteins or their polypeptides. The LP-B was 
precipitated by antibodies to LP-B, and the LP-A was separated from LP-C
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by precipitation of LP-C with 33% polyethylene glycol (PEG) or by elution 
from a hydroxyapatite column with 0.25 M phosphate buffer. The material 
obtained from the supernate of the PEG precipitate or the elutant of the 
hydroxyapatite reacted only with antibodies to LP-A. Resolution of to­
tally delipidized LP-A into two major components was achieved by gel fil­
tration on Sephadex G-75. At this point, neither component was immuno­
chemically homogeneous. Each polypeptide fraction was further purified 
by column chromatography on DEAE-cellulose in the presence of 8 M urea, 
followed by gel filtration on G-75. The two polypeptides purified in 
this fashion were tested immunochemically with antibodies to LP-A and/or 
antibodies to R-Thr; they gave on direct comparison a non-identity reac­
tion. The mobility on polyacrylamide gel and the amino acid composition 
of each isolated polypeptide were comparable to those reported previously 
for R-Thr and R-Gln (126). Terminal amino acids of R-Thr and R-Gln were 
investigated, and the N-terminal for R-Thr was found to be aspartic acid. 
No N-terminal for R-Gln was identified. By kinetic experiments with car­
boxypeptidase A, both R-Thr and R-Gln had glutamine as the carboxy ter­
minal amino acid. It was proposed that the "R-Thr" peptide be designated 
as "R-Gln-I" and "R-Gln" be designated as "R-Gln-II." The minimum molec­
ular weight by sedimentation equilibrium was 14,000 for "R-Gln-II" and
24,000 for "R-Gln-I." The latter value was confirmed by results of tryp­
tic hydrolysis.
Polypeptide Composition of ApoB 
At the present time the polypeptide composition of ApoB remains 
unclear. Several investigators have suggested that ApoB may contain two 
or more non-identical polypeptides, but there exists no unequivocal proof
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Two antigenic components have been reported to be present in LP-B (89,
90). The differences in amino acid composition of two subfractions of 
immunochemically pure LP-B suggested the presence of two unequally dis­
tributed ApoB polypeptides (90). Two fractions isolated from DEAE-cellu­
lose chromatography had different amino acid compositions and comprised 
only 30% of the starting material (121). Modification of LP-B with sub­
sequent total delipidization yielded a soluble maleylated apolipoprotein 
B preparation which was resolved by gel permeation on Sephadex G-150 or 
G-200 (93, 131) into two fractions with different amino acid analyses and 
immunochemical behavior. By the use of positively charged disulfide ex­
change reagents and monitoring the behavior of modified ApoB on electro­
phoresis, it was suggested that ApoB contained at least two non-identical 
polypeptides (132).
Classification Systems 
Until recently the two classification systems for plasma lipo­
proteins were based either on their hydrated densities or electrical 
charge as the two most characteristic physical-chemical properties. The 
differential flotation of lipoproteins by ultracentrifugation resulted 
in the recognition of five density classes based on the observed maximal 
and minimal concentrations of lipoproteins along a density gradient be­
tween approximately 0.92 and 1.21 g/ral (21-23). As already mentioned, 
all the density classes have been shown to be heterogeneous by terminal 
amino acids (74, 109, 113), immunochemical studies (3, 90, 60, 107, 108), 
and, most recently, by the isolation of non-identical polypeptides (126, 
118, 121, 128). These density classes have also been shown to be poly- 
disperse systems with respect to particle size and hydrated density
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(24, 25).
The other classification system, based on electrical charge, 
recognizes three major bands or groups of lipoproteins designated as uj-, 
a^- and 6-LP. However, since lipoproteins with these electrophoretic mo­
bilities correspond (26-28) roughly to the HDL, VLDL, and LDL, respective­
ly, they also represent mixtures rather than distinct lipoprotein spec­
ies.
To account for the reported protein heterogeneity of the vari­
ous density classes, a classification system based on apolipoproteins as 
the only distinct chemical components of lipoproteins has been proposed 
(2) for the differentiation of lipoprotein families. Lipoprotein famil­
ies were defined as "polydisperse systems of lipid-protein complexes 
characterized by the presence of a single, distinct apolipoprotein or its 
constitutive polypeptides" (130). The chemical concept currently recog­
nizes the existence of three distinct lipoprotein families: lipoprotein
family LP-A, characterized by the presence of apolipoprotein A; lipopro­
tein family LP-B, by apolipoprotein B; and lipoprotein family LP-C, by 
apolipoprotein C. Some of the characteristics of the lipoprotein families 
are listed in Table 8 which summarizes the available information such as 
number of peptides, terminal amino acids, and antigenic components assoc­
iated with each family. It should be pointed out that this division of 
lipoproteins into only three lipoprotein families can be readily expanded 
if some of the already characterized polypeptides are found to be the 
protein moiety of a distinct lipoprotein or if new polypeptides are iso­
lated and shown to be the apolipoprotein of a new lipoprotein family.
Although the operational nomenclature of plasma lipoproteins
TABLE 8
THE EXPANDED CHEMICAL NOMENCLATURE OF HUMAN PLASMA LIPOPROTEINS
Lipoprotein
Family
Apo­
lipoprotein
Constitutive
Polypeptides
N-terminal 
Amino Acid
C-terminal 
Amino Acid
Amino Acid 
Deletion
Antigenic 
Component(s)
Literature
Designation
LP-A ApoA A-1 Aspartic
acid
Glutamine H e ,
1/2 Cys
Single R-Thr
A-II Blocked Glutamine His, Arg, 
Try
Single R-Gln
LP-B ApoB B Glutamic
acid
(Serine) None One-two
LP-C ApoC C-I Threonine (Valine) His, Tyr,
1/2 Cys
Single R-Val
C-II Threonine (Glutamic
acid)
His,
1/2 Cys
Single R—Glu
C-III-1*
C-III-2*
Serine
Serine
Alanine
Alanine
H e ,
1/2 Cys
H e ,
1/2 Cys
► Single R-Ala
C-III-1 and C-III-2 represent the polymorphic forms of C-III peptide. The Roman numerals re­
fer to the parent polypeptide, while the Arabic numerals designate the polymorphic forms.
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based on ultracentrifugal and/or electrophoretic isolation is fully jus­
tified when properly applied to specific preparations, the chemical no­
menclature based on apolipoproteins as the unique and specific criterion 
for differentiation of lipoproteins seems to reflect better and describe 
more adequately the complexity of lipoprotein chemistry and metabolism 
under normal and pathological conditions. The chemical nomenclature used 
in this dissertation is presented in its expanded form in Table 8.
CHAPTER III
MATERIALS AND METHODS
Materials
Human Plasma and Serum 
Venous blood was obtained from normal, healthy male and female 
donors after an overnight fast. The plasma was collected by plasmaphere­
sis in a 600 ml plastic bag containing 2.2% sodium citrate (Fenwal Lab., 
Morton Grove, 111.). Plasma triglycerides (TO), phospholipids (PL), and 
cholesterol (C) were analyzed in each case to determine whether or not 
the lipid values were within the normal levels (TO < 150 mg%, PL < 250 
mg%, and C < 250 mg%). The plasma samples with normal lipid values were 
designated as "normal fasting plasma."
Large quantities of plasma (5-10 liters) were obtained from the 
plasmapheresis laboratory of the Oklahoma Medical Research Foundation. 
These plasma samples were designated as "random plasma" because the di­
etary condition of the presumably normal, healthy doners was unknown.
Blood samples were also obtained from two pat ients with "mixed 
type" hypertriglyceridemia (Type V). A small quantity of venous blood 
was drawn after an overnight fast and was immediately followed by the in­
gestion of a heavy fat load (milk shake). Five hours after the oral fat 
load, 500 ml of blood were drawn. The blood was allowed to stand for
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several hours, and the clot was removed by low speed centrifugation. The 
former serum sample was labeled "fasting hypertriglyceridemia serum" and 
the latter "postprandial hypertriglyceridemia plasma." One large sample 
(5,000 ml) was obtained from nine hypertriglyceridemia (Type IV and Type 
V) subjects by plasmapheresis.
Jaundiced subjects with various kinds of liver disease were 
checked for the presence of LP-X by the immunochemical test described by 
Seidel e^ al. (96). If the serum tested was positive for LP-X, then a 
larger volume of plasma was collected by plasmapheresis and designated 
"obstructive jaundiced plasma."
Human Chyle
Chyle samples were obtained through the cooperation and courtesy 
of W. H. Falor, M.D., Akron, Ohio. This material was obtained by cannu- 
lation of the left thoracic duct of individuals with the diagnosis of 
carcinoma of the lung or some other thoracic ailment. Chyle was collected 
continuously for several days at 12-hour intervals beginning two hours 
after the patients had ingested 150-200 g of heavy cream; the subsequent 
diet contained 75% calories from fat which consisted mainly of half-and- 
half cream. In some cases the diet for the last few collections was 
dextrose-water. Any fibrin strands formed during shipment via air ex­
press were removed by filtration through cheesecloth. The fluid remain­
ing in the clots was recovered by applying pressure to the fibrin 
strands. Most chyle samples were pooled and used for subsequent prepar­
ative procedures; however, some Individual samples were studied sepa­
rately, i.e., the more lactescent sample and the sample obtained after 
the dextrose-water feeding.
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Miscellaneous Material
Human autopsy material was btained through the courtesy of Y. 
Stein, M.D., The Hebrew University, Hadassah Medical School, Jerusalem, 
Israel. The samples including serum, liver tissue, and intestinal muco­
sal scrapings were obtained within 2 to 4 hours after death. Liver and 
mucosal scrapings were homogenized, and the cellular debris was removed 
by low-speed centrifugation.
Fasting (0 hr) and postprandial plasma samples (6 and 24 hrs) 
from hypertriglyceridemia patients with Type III or T>pe IV disease were 
obtained through the cooperation of Wm. Hazzard, M.D., Seattle,
Washington. In some cases VLDL subfractions consisting of S^ > 400 and 
Sj 20-400 isolated at each time interval were sent either in the intact 
form or as 8-, «2“ aj-fractions separated by starch electrophoresis.
Chemicals
Ammonium carbonate, magnesium chloride, guanidine monohydrochlor­
ide, mercaptoethanol, disodium salt of EDTA, sodium hydroxide, hydrochlor­
ic acid, glacial acetic acid, potassium phosphate (mono and di-basic) , 
phosphoric acid, 2-amino-2-(hydroxymethyl)-1,3-propanediol (Tris), 8-ala­
nine, glycine, urea, iodine, petroleum ether, and n-heptane were purchased 
from J. T. Baker Chemical Co., Phillipsburg, N. J.; sodium chloride, so­
dium carbonate, sodium citrate, sulfuric acid, ethylenediamine, barbit­
uric acid, barbital, trichloroacetic acid, chloroform, and peroxide-free 
diethyl ether, from Mallinckrodt Chemical Works, St. louis. Mo.; potassium 
bromide, from Fisher Scientific Co., Fair Lawn, N. J.; polyethylene gly­
col, from Matheson, Coleman, and Bell, Norwood, Ohio; sodium azide, Bromo- 
phenol Blue, Amido Black lOB, sodium dodecyl sulfate, and mepesulfate.
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from K&K Laboratories, Inc., Hollywood, Calif.; heparin sodium, from Nu­
tritional Biochemical Corp., Cleveland, Ohio; phosphotungstic acid, from 
B&A, Morristown, N. J.; Coomassie Brilliant Blue R-250, from Co-Lab, 
Chicago, 111.; Oil-Red-0 and Pyronin B, from Allied Chemical Corp., New 
York, N. Y. ; acrylaraide, N,N'-methylenebisacrylamide (Bis), riboflavin, 
N,N,N'N^-tetracethylethylenediamine (TEMED), and ammonium persulfate, from 
Canalco, Rockville, Md.; absolute and 95% ethanol, from U.S. Industrial 
Chemicals Co., New York, N. Y.; special Agar-Noble and Freund's complete 
adjuvant, from Difco Lab., Detroit, Mich.; agarose from Bio-Rad Lab., 
Richmond, Calif.; anhydrous hydrazine, from Pierce Chemical Co., Rockford,
111.; l-dimethylarainonaphthalene-5-sulfonyl chloride (DNS-Cl), from Cal- 
biochem, Los Angeles, Calif.; DNS-amino acid standards, from Mann Research 
Lab, New York, N. Y.; carboxypeptidase A, carboxypeptidase B, and trypsin, 
from Worthington Biochemical Corp., Freehold, N. J.; human albumin, from 
Certified Blood Donor Service, Woodbury, N. Y . ; lysozyme, cytochrome c, 
ribonuclease, and ovalbumin, from Sigma Chemical Co., St. Louis, Mo.; Blue 
Dextran, from Pharmacia Fine Chemicals, Inc., Pitscataway, N. J.; and No- 
jax cellulose casing. Size 18, from Union Carbide, Chicago, 111.
Methods
Isolation of Lipoproteins 
Ultracentrifugal methods. For analytical purposes 7 ml of plas­
ma or serum were overlayered with 4 ml of 0.15 M NaCl in 0.1% EDTA and 
centrifuged in the Type T150 rotor of the Model L preparative ultracen­
trifuge (Beckman Instruments, Inc., Palo Alto, Calif.) for 22 hours at
105,000 X  g at 4*C. After completion of the ultracentrifugal run, the
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top 2 ml were removed by a tube-slicing technique to yield the VLDl,
> 20 (3). The LDL (1.006-1.063 g/ml), HDL^ (1.063-1.125 g/ml), and 
HDLg (1.125-1.21 g/ml) were isolated sequentially by adjusting the solu­
tion density of the infranate with KBr to 1.063, 1.125, and 1.21 g/ml and 
centrifuging for 22 hours at 105,000 x g (3). A scheme for the fraction­
ation of lipoproteins is shown in Fig. 1. Occasionally the LDL was sub- 
fractionated into LDL^ (1.006-1.019 g/ml) and LDL2 (1.019-1.063 g/ml).
In some cases the HDL2 and HDL^ were isolated as one density class, HDL 
(1.063-1.21 g/ml).
The VLDL was fractionated into five subfractions or combinations
of these subfractions as described by Gustafson e^ (114) . These sub­
fractions are defined as A (S^ > 5,000), B (S^ 400-5,000), C (S^ 100-400), 
D (S^ 50-100), and E (S^ 20-50). The centrifugally isolated lipoprotein 
density classes were "purified" by repeated flotations in the prepara­
tive ultracentrifuge under their original isolation conditions. Purity 
of various lipoprotein fractions was determined by the absence of albu­
min as demonstrated by double diffusion tests with antibodies to albumin.
To isolate larger amounts of VLDL in a single run, the plasma
was spun at its original density (1.023-1.027 g/ml) in either the Type
Ti60 or H42 rotor of the Model L2-50 or L2-65-B ultracentrifuge (Beckman 
Instruments, Inc., Palo Alto, Calif.) for 22 hours at 105,000 x g. The 
lipoprotein layer was removed by a tube-slicing technique and washed two 
times by recentrifugation under identical conditions. The isolated lipo­
proteins were used for preparative purposes and were designated VLDL.
In some instances, when large volumes of chyle had to be immed­
iately processed, the chylomicrons (S^ > 400) were isolated by centri-
Plasma
1
VLDL 
(d < 1.006 g/ml)
Layering with 0.15 M NaCl 
Centrifugation at 105,000 x jg 
for 22 hours
Adjustment of density to 1.063 g/ml 
Centrifugation at 105,000 x 
for 22 hours
1
LDL
(1.006-1.063 g/ml)
Adjustment of density to 1.125 g/ml 
Centrifugation at 105,000 x g  
for 22 hours
HDLg
(1.063-Î7Î25 g/ml)
Adjustment of density to 1.21 g/ml 
Centrifugation at 105,000 x g  
for 22 hours
HDL]
(1.125-Ï72Î g/ml)
4
1.21 g/ml Infranate
p-f/ 1 Ultracentrtfugal Isolating ''-Apoproteins.
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fuging chyle in the GSA rotor of the Servall centrifuge (Ivan Sorvail, 
Inc., Norwalk, Conn.) at 1 x 10^ g-min. The required amount of ultracen­
trifugation was calculated from an experimentally determined nomogram 
(114). The centrifugation was done at the chyle density with no over­
layering of a saline solution. The isolated chylomicrons were then re­
peatedly washed in a preparative ultracentrifuge until free of albumin.
Precipitation methods. Most of the precipitation procedures 
were carried out with either plasma or isolated density classes. Cohn's 
Method 10 (133) was utilized for both plasma and VLDL to obtain Cohn 
fractions I-III, IV-V, and VI. The sulfated polysaccharides, heparin 
(40) and mepesulfate (33), were utilized to precipitate lipoproteins with 
an approximate > 0. When plasma was used as the starting material, it 
was necessary to wash the dissolved lipoprotein precipitate at least once 
by ultracentrifugation at d 1.073 g/ml for 22 hours at 105,000 g min to 
remove contaminating serum proteins.
Polyethylene glycol precipitation, as described by Kostner and 
Alaupovic (134), was applied to intact and partially delipidized VLDL.
To a 1 ml sample, 0.1 g of NaBr and 0.6 ml of 33% polyethylene glycol 
were added. The precipitate separated from the soluble portion by low- 
speed centrifugation was dissolved in 0.1 M (NH^)2C0g. The dissolved 
precipitate and the soluble portion were tested by double diffusion.
Phosphotungstate precipitation (41) of lipoproteins was found 
to be a useful procedure for the preparative isolation of large quanti­
ties of plasma lipoproteins. Fifty milliliters of a 4% solution of phos­
photungstate (pH 7.6) were added to 500 ml of plasma, followed by the ad­
dition of 12.5 ml of 2 M MgCl^. An immediate turbidity developed; the
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precipitate (ppt. I) was removed by low-speed centrifugation, and the 
supernates were used for further precipitation. Four hundred and fifty 
milliliters of the 4% phosphotungstate solution were added to the com­
bined supernates, and the mixture was allowed to stand until a fine pre­
cipitate developed. The supernate was aspirated and utilized for the 
next step. The precipitate was discarded. Addition of 87.5 ml of 2 M 
MgClg to the supernate resulted, after an overnight storage at 4°, in a 
precipitate (ppt. II) which was recovered by low-speed centrifugation.
Both ppt. I and ppt. II were dissolved in 1 M NagCO^ by prolonged stir­
ring. Precipitate I was centrifuged sequentially (Fig. 2) at densities
1.073 g/ml, 1.030 g/ml, and 1.073 g/ml for 22 hours at 105,000 g to iso­
late the two fractions designated VLDL (d < 1.030 g/ml) and LDL (1.030-
1.073 g/ml). The density of precipitate II was adjusted to 1.23 g/ml by 
the addition of KBr, and the mixture was centrifuged in the Ti60 rotor of 
Spinco Model L2-65-B ultracentrifuge for 22 hours at 165,000 g. The top 
layer (HDL, d < 1.23 g/ml) was collected and washed two times by recen­
trifugation under identical conditions. Infranates from the original 
centrifugations and washes were discarded. Whereas precipitate I or its 
fractions (VLDL and LDL) were free of immunochemically detectable albumin 
after two ultracentrifugations, HDL still contained traces of albumin.
Up to 10 liters of plasma could be handled satisfactorily by this frac­
tionation procedure (Fig. 2). The lipoproteins were dialyzed exhaustively 
against distilled water, totally delipidized, and used as a source of 
ApoC, ApoA, and ApoB.
Lipoprotein X (LP-X) was isolated as described previously (96). 
Column chromatographic techniques. Sepharose 4B or 6B (Pharmacia
500 ml of plasma
I-----
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50 ml of 4% phosphotungstate, pH 
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7.6
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1.073 g/ml 
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at 105,000 X 2  
for 22 hours
r
450 ml of 4% phosphotungstate, pH 
Aspiration of supernate
7.6
Supernate
Adjustment 
of density 
to 1.030 g/ml 
Centrifugation 
at 105,000 X ^  
for 22 hours
Infranate
(Discard)
Precipitate
(Discard)
Supernate
Infranate
Adjustment of
density to
1.073 g/ml
Centrifugation
at 105,000 X
for 22 hours
 1
VLDL 
(d < 1.03 g/ml)
I
Precipitate II
87.5 ml of 2 M MgClg 
Aspiration of supernate 
Low-speed centrifugation 
of precipitate
r
Infranate
(Discard)
r
— I
Supernate
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Centrifugation at 
165,000 X  for 22 hours 
Repeat for a total of 
3 times
LDL Infranate HDL
(d 1.03-1.073 g/ml) (Discard) (d < 1.23 g/ml)
Figure 2. Isolation of lipoproteins by phosphotungstate precipitation,
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Fine Chemicals, Piscataway, N. J.) was equilibrated with the buffer, fines 
removed, deaerated, and poured into a column 2.5 x 100 cm (Glenco Scien­
tific, Inc., Houston, Texas). Flow rate was held constant during each 
run with all chromatographic procedures being conducted at room temper­
ature. Lipoprotein density classes or partially delipidized lipoproteins 
were applied to the column in a volume of 3 to 5 ml. Four to five ml 
fractions were collected and monitored continuously with a Uviscan III-A 
(Buchler Inst., Inc., Fort Lee, N. J.) at 254 m p ; alternatively, each 
fraction was monitored at 280 mu in a spectrophotometer (Gilford Instru­
ment Lab Inc., Oberlin, Ohio).
Sephadex G-200, G-lOO, G-75, and G-25 (Pharmacia) were either 
equilibrated with the appropriate buffer for several days or placed in a 
boiling water bath to swell the gel and then equilibrated with buffer. 
Fines were decanted and the gels were poured into the columns. G-200 
columns (2.5 x 100 cm) were used primarily for the separation of lipopro­
teins; Sephadex G-lOO and G-75 columns (2.5 x 100 cm) were used for frac­
tionating the apolipoproteins, and Sephadex G-25 columns (2.5 x 60 cm) 
for desalting.
Diethylaminoethyl (DEAE) cellulose (Bio-Rad Laboratories, 
Richmond, Calif., 0.40 mEq/g dry weight) was utilized for the ion exchange 
chromatography of both lipoproteins and apolipoproteins. One-hundred 
grams of DEAE-cellulose were washed successively with 0.5 N NaOH, dis­
tilled water, 0.5 N HCl, and distilled water. The pH value of the washed 
DEAE-cellulose was adjusted to that desired for the operation of the col­
umn. After washing with the appropriate buffer, the DEAE-cellulose was 
poured into the column (1.5 x 30 cm) and further equilibrated with the
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buffer. If 8 M urea was utilized in the buffer system, the most satis­
factory equilibration with the urea-buffer system was achieved when the 
urea solution was added to the already packed column. The pH of the ef­
fluent was checked before the sample was added, and the flow rate was 
usually 30-40 ml/hr. Gradient formation was either linear or concave de­
pending on the manipulation of the gradient vessels (135).
Hydroxyapatite (Bio-Rad) was washed several times with 0.01 M 
phosphate buffer (pH 6.8) and then poured into a 1.5 x 30 cm column 
(Glenco). The sample was applied to the hydroxyapatite column and eluted 
with stepwise increments of phosphate buffer: 0.01 M, 0.25 M, 0.40 M,
0.65 M, and 0.1 M sodium citrate.
All fractions eluted from the columns were monitored by adsorp­
tion at 280 mp or 254 mp, immunodiffusion, and polyacrylamide disc gel 
electrophoresis.
Delipidization of Lipoproteins 
Partial delipidization. Partial delipidization of lipoproteins 
was carried out according to the procedure by Gustafson (116) as modified 
by Ledford £t (136). The lipoprotein samples were dialyzed exhaus­
tively against distilled water and lyophilized without starch in a 50 ml 
glass stoppered centrifuge tube. The dried lipoproteins were extracted 
with n-heptane at least five times or until the organic phase was color­
less. The residue was dried at room temperature and then dissolved in 
0.1 M borate buffer (pH 8.6). The insoluble material was removed by low- 
speed centrifugation.
Total delipidization. Total delipidization of lipoproteins was 
carried out essentially as described by Scanu et al. (137). Exhaustive
Afa
dialysis of the sample against distilled water preceded lyophllizaiion.
The delipidization procedure was begun by treatment of the lyophilized 
material with absolute ethanol-diethyl ether (3:1, v/v) on a rotator 
(15 rpm for 30 min) with a total of 5-8 extractions, followed by low- 
speed centrifugation to remove the solvent. In the final step the resi­
due was extracted overnight with ethanol-diethyl ether (2 :1 , v/v) followed 
by 3-5 extractions with diethyl ether. All extractions were carried out 
at 6 °C. The residue was dried at room temperature and usually contained 
less than 1 % phospholipid.
Isolation of Partially Delipidized Lipoprotein C
Isolation by immunoprécipitation. The soluble portion of the 
partially delipidized "postprandial hypertriglyceridemic" VLDL represent­
ed the principal source for the isolation of partially delipidized LP-C 
(pdLP-C).
Immunoprécipitation of pdLP-A and pdLP-B was accomplished by the 
use of delipoproteinated antisera to HDL^ and LDL, respectively. To 
avoid contamination with rabbit lipoproteins, the antisera were adjusted 
to d 1.25 g/ml and centrifuged for 22 hours at 120,000 x g. The floating 
lipoproteins were removed by a tube-slicing technique and discarded. 
Antibodies in the infranate were dialyzed against several changes of 
saline. Optical ratios for immunoprécipitation of LP-B and LP-A were 
determined by o serial micro dilution method as described under immuno­
logical methv-us. The appropriate amounts of delipoproteinated antisera 
were added successively to the pdVLDL dissolved in 0.1 M borate buffer, 
pH 8 .6 , and the reaction mixtures were allowed to stand for two hours at 
37*C (Fig. 3). The Immunopreclpltates were removed by low-speed centri-
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Soluble partially delipidized VLDL
Incubated with A-HDL^ 
for 2 hours at 37“C 
Centrifugation at low speed
Immunoprecipitate pdVLDL
(pdLP-C:LP-B)
Incubated with A-LP-B 
for 2 hours at 37°C 
Centrifugation at low speed
pdVLDL
(pdLP-C)
Infranate 
(Rabbit serum proteins)
Immunoprecipitate
Density adjusted to 1.21 g/ml 
Centrifugation at 105,000 x ^  
for 44 hours
 1
Supernate
Partially delipidized LP-C
Figure 3. Isolation of partially delipidized LP-C by immunopré­
cipitation.
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fugation, and the supernates were checked for the possible presence of 
pdLP-B and pdLP-A by double diffusion. If these antigenic components 
were still present, the precipitation procedure was repeated until there 
was no reaction with antibodies to LDL or HDL^. The density of the su­
pernate was adjusted to 1 . 2 1  g/ml, and the solution was centrifuged for 
22 hours at 105,000 x g. The top fraction contained the pdLP-C and no 
rabbit plasma proteins, as demonstrated by immunodiffusion with antibodies 
to rabbit whole plasma.
Isolation by ultracentrifugation. Due to the presence of anti­
bodies to LP-C in the anti-HDL^ serum, another method was developed to 
isolate the pdLP-C. This method was based on the hydrated density of 
pdLP-C (d = 1.09 g/ml) determined by Gustafson et al. (3). The density 
of the soluble pdVLDL was adjusted to 1.04 g/ml, and the solution was 
centrifuged for 22 hours at 105,000 x g (Fig. 4). The supernate was dis­
carded, and the density of the infranate was increased to 1.12 g/ml. The 
centrifugation of the infranate ^or 22 hours at 105,000 x g yielded a 
floating lipoprotein fraction with a density range of 1.04-1.12 g/ml.
This fraction, containing the pdLP-C, was washed several times by recen­
trifugation under the original conditions until Fraction C was immunochem­
ically free of pdLP-A and pdLP-B. The density of the combined washings 
and original infranate stemming from centrifugation at 1 . 1 2  g/ml was ad­
justed to 1 . 2 1  g/ml, and the mixture was centrifuged for 2 2 hours at
105,000 X  g. The supernate (Fraction ABC) contained an additional amount 
of pdLP-C.
Isolation and Fractionation of ApoC
Although the ultracentrifugal procedure represents the method of
Partially delipidized VLDL
Adjustment of density to 1.04 g/ml 
Centrifugation at 105,000 x 
for 2 2 hours
■|
d •' 1.04 g/ml 
(Traces of pdLP-A, 
pdLP-B and pdLP-C)
Infranate
I
d 1.04-1.12 g/ml
Adjustment of density to 1.12 g/ml 
Centrifugation at 105,000 x ^  
for 2 2  hours
This step repeated 
until free of 
pdLP-A and pdLP-B
Infranate
Adjustment of density 
to 1 . 1 2  g/ml
Centrifugation at 105,000 x ^  
for 2 2 hours
Adjustment of density to 1.21 g/ml 
Centrifugation at 105,000 x ^  
for 2 2 hours
Partially delipidized LP-C Partially delipidized 
LP-A, LP-B and LP—C
(Fraction C) (Fraction ABC)
Figure 4. Ultracentrifugal isolation of partially delipidized lipoprotein C.
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I III) i ru for Llie Isolation of pilLP-C, it is too lime consuming and compli­
cated for the preparative isolation of ApoC. To facilitate the isolation 
of ApoC, either the ultracentrifugally isolated VLDL or the phosphotung­
state precipitate was totally delipidized according to the procedure de­
scribed previously. Precipitate I (d 1.030 g/ml) was the major source 
of ApoC from the phosphotungstate procedure.
Totally delipidized lipoprotein preparations were only partially 
soluble in 0.1 M (NH^)2 C0 g due to the insolubility of ApoB in aqueous 
buffers. The soluble protein was separated from the aggregated material 
by low-speed centrifugation. After three repeated treatments of insol­
uble residue with 0.1 M (NH^)2 C0 g, the soluble portions were combined and 
lyophilized (solute 1). The remaining aggregated protein was treated 
with 6 M guanidine*HC1 in 0.1 M mercaptoethanol, as described by Lee and 
Alaupovic (138), with overnight stirring, followed by removal of any in­
soluble material by low-speed centrifugation. The soluble portion was 
diluted with distilled water to an approximately 3 M solution with re­
spect to the guanidine*HC1 and then dialyzed exhaustively against dis­
tilled water to precipitate ApoB and to keep ApoC and ApoA in solution.
The insoluble material, representing mainly ApoB, was treated two times 
in the same fashion; and the three soluble portions were combined (solute 
2). Since the remaining insoluble residue was soluble in 50% acetic acid, 
the extraction procedure involving dialysis of the acetic acid solution 
against distilled water with ensuing precipitation of ApoB was repeated 
three times. The soluble portions (solute 3) were combined with solutes 
1 and 2, dialyzed against distilled water, and lyophilized. This lyo­
philized preparation was used for the subsequent isolation of ApoC.
1)1
The ApoC was isolated by gel permeation of the soluble apolipo- 
protein preparation on a Sephadex G-75 or G-lOO column (1 x 36 in) equi­
librated with 0.1 M (NH^ÏgCOj, pH 9 0. Fractions corresponding to tlie 
elution peaks were combined and lyophilized; the ApoC peak was utilized 
for further fractionation.
Further fractionation of ApoC was attempted by several different 
procedures. One was the use of preparative electrofocusing as described 
in the LKB instruction manual. The 440 ml column (LKB, Brona, Sweden) 
was used for a large amount of ApoC (200 mg) and the 110 column (LKB) 
for smaller quantities, such as subfractions of the 440 ml column. Se­
lection of the proper ampholine range for preparative focusing was deter­
mined from the results of analytical electrofocusing. All solutions were 
prepared as directed except that they were made 7 M with respect to urea. 
Electrofocusing was begun at an initial voltage of 400 volts for approx­
imately 12 hours and then increased to 700 volts with the column being 
cooled with tap water (16-18°C). Focusing was terminated when the amper­
age became constant (48-72 hr). The column was drained in 2 ml fractions 
at 2 ml/min and monitored at 280 mp, with the pH and disc gel pattern de­
termined for every other fraction.
For preparative purposes the 440 ml column was utilized with a 
2% ampholine solution. Elution of the 440 ml column was monitored by 
absorption at 280 my and disc gel electrophoresis. From this information 
fractions were pooled and refocused on the 1 1 0  ml column and monitored 
as described previously.
Another procedure utilized to fractionate the ApoC peak was the 
use of DEAE-cellulose in the presence of 8 M urea. The gradient-fc rming
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device (Glenco) was set to form a concave gradient by stoppering vessel
I which was attached to the column. Vessel I contained 350 ml of .003 M 
phosphate buffer (pH 7.2) in 8  M urea, and vessel II contained 500 ml of 
the same buffer with 0.10 M NaCl used to form the gradient. After vessel
II was empty, 250 ml of phosphate-urea buffer in 2 M NaCl were added; the 
elution procedure was concluded by the addition of glacial acetic acid. 
The elutant was analyzed continuously at 254 mp and the peaks were ex­
amined by disc gel electrophoresis. Elution peaks were dialyzed exhaus­
tively against distilled water and lyophilized.
Preparative discontinuous polyacrylamide gel electrophoresis was 
performed using the Buchler Fractophorator (Buchler Instruments, Fort 
Lee, N. J.). The gels were identical to those used on the analytical 
scale with both the acidic and basic buffer systems. Separation on 5,
6 and 7% separating gels in 8  M  urea was examined and it was decided that 
the 7% gel was the most satisfactory. The separating gel (4 ml) was pre­
pared in 8 M urea, whereas stacking and sample gels were prepared in 4 M 
urea. Although a Tris-glycine buffer, pH 8.3, was utilized initially, 
it was found later that the Tris-borate buffer, pH 9.0, was just as sat­
isfactory. Pre-electrophoresis for 30 minutes at 12 milliamperes was 
followed by application of the sample in a volume of 1-3 ml which was 
overlayered with buffer containing the tracking dye Bromophenol Blue. 
Electrophoresis was carried out at a constant amperage (10 ma) and at 
room temperature. Four milliliter fractions were collected every 2.5 
minutes, and the electrophoresis was usually completed in four hours.
The fractions were monitored at 280 mp, and every second tube of the peak 
and/or peaks was examined by IX disc gel electrophoresis with an accom-
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panying VLDL sample as a standard. Fractions eluted from the gel were 
combined on the basis of the analytical polyacrylamide patterns. Frac­
tions containing pure polypeptides were dialyzed exhaustively against 
distilled water and utilized for subsequent analyses.
Electrophoretic Techniques 
Polyacrylamide gel electrophoresis. Analytical discontinuous 
polyacrylamide gel electrophoresis was carried out essentially as de­
scribed by Davis (53) with equipment from Canalco, Rockville, Maryland. 
Separating gels of 3% and 7% by weight were used in the basic buffer sys­
tem, while only 7% gels were used in the acidic buffer system (139). 
Tris-glycine (pH 8.3) and Tris-g-alanine (pH 4.5) were utilized for the 
two systems. The electrophoretic separation on 7% gels was usually car­
ried out with 8 M urea in the separating gel and 4 M urea in both the 
stacking and separating gels. Electrophoresis was carried out at 4.5 
ma/tube with the tracking dye (basic, Bromophenol Blue; acidic, Pyronin 
B) migrating a constant distance of approximately 4 cm into the separating 
gel during each run. The gels were originally fixed with a solution of 
1% Amido Black lOB in 7% acetic acid followed by electrophoretic d stain­
ing. This procedure was found to be tedious and somewhat questionable 
as to whether or not some bands were removed by electrophoretic de stain­
ing. In the course of this study, it was found that placing the gels 
directly into a solution of 0.12% Coomassie Brilliant Blue in 10% tri­
chloroacetic acid (0.25/10, v/v) was very satisfactory for both fixing 
and staining the separated polypeptides. After approximately 48 hours, 
the background became perfectly clear with only the stained, fixed protein 
bands visible. The gels were then transferred to a water solution to
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prevent destaining of the fixed band.
Polyacrylamide gel electrophoresis combined with immunodiffusion. 
Samples were separated by the basic 7% polyacrylamide gel electrophore­
sis system, and the gels were sliced longitudinally into halves. Sliced 
gels were placed flat side down on microscopic slides, and approximately 
4 ml of a 1% agarose solution in Veronal buffer, pH 8 .6 , at 50*C were 
poured around each gel. The agarose-acrylamide gel was allowed to set 
for one hour. Longitudinal troughs were then cut on each side of the 
acrylamide gel and the appropriate antisera were added.
The horizontal regions, corresponding to bands visualized in 
separately stained gels, were sliced from the 7% gels and examined by 
immunodiffusion and Immunoelectrophoresis. The slices from the acryl­
amide gel were treated in the same manner as described for the longitud­
inally sliced gels.
Scanning of some of the separating gels was carried out using 
the linear transport module (Gilford Instrument Laboratories, Inc., 
Oberlin, Ohio) at 550 my at a scan speed of 1 cm/min with recording speed 
of 4 cm/min in order to achieve maximum resolution of the bands in the 
gel. The areas under the peaks were determined by triangulation 
(H X  W ^ y 2 ij) or by use of a planimeter (Keuffer & Esser Co., New York).
Analytical electrofocusing (56) was carried out in the Canalco 
disc gel electrophoresis equipme ' imploying a constant voltage power 
supply. Ampholine 3-10 (LKB, Bromma, Sweden) was found to be the most 
useful carrier ampholyte for screening purposes, although ampholines with 
narrower pH ranges were also utilized when necessary. Samples were mixed 
with ampholine, acrylamide, blsacrylamlde, TEMED, and ammonium persulfate
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and allowed to polymerize in a I.D. tube (10 x 0.4 cm) to form a 1% am­
pholine solution in a 5% polyacrylamide gel. Electrofocusing was carried 
out for 16 hours at 2 0 0  volts and 6 -8 “ with 1% phosphoric acid at the 
cathode and 1% ethanolamine at the anode. The most satisfactory stain­
ing procedure was found to be 0.12% Coomassie Brilliant Blue in 10% TCA 
(.25:10, v/v) as described for the disc gels.
Agarose or agar electrophoresis was carried out as described for 
immunoelectrophoresis except that the sample (20-30 X) mixed with equal 
volumes of agar or agarose (all done at approximately 50“C) was placed 
into a slot (1 x 0 . 1  cm) which was covered with agarose to give a leveled 
surface. After completion of electrophoresis, the slides were fixed in 
10% TCA for one hour and washed in distilled water for approximately two 
hours with two changes of water. Washed slides were then covered with 
lintless paper and allowed to dry overnight with subsequent staining with 
Amido Black lOB or Oil Red 0.
Paper electrophoresis was carried out as described by Lees and 
Hatch (50) with a Durrum cell and Veronal buffer, pH 8 .6 , containing 1% 
human serum albumin. The dried paper strips were stained with Oil Red 0 
in an 80“C oven.
Molecular Weight Determination by Polyacrylamide 
Gel Electrophoresis
Determination of the molecular weight of polypeptides by 5% 
polyacrylamide gel electrophoresis in the presence of sodium dodecyl sul­
fate was carried out according to the procedure described by Shapiro 
et al. (140). Human albumin, ovalbumin, trypsin, and lysozyme were used 
as standards. The gels were fixed and stained with the Coomassie Bril-
5(,
liant Bluc-TCA staining procedure.
Analytical Ultracentrifugation 
The analytical ultracentrifugation of lipoproteins was carried 
out in a Spinco Model E analytical ultracentrifuge equipped with schlieren 
and interference optical systems, a RITC unit, and an electronic speed 
control unit. Photographs were taken automatically by the photographic 
apparatus of the ultracentrifuge. Plate measurements were made with a 
Nippon Kogaku KK Shadowgraph Model 6 .
Samples for sedimentation rate were equilibrated with 0.15 M 
NaCl or some other appropriate buffer. Sedimentation experiments were 
carried out in single-sector cells at 56,100 rpm at 25“C, and the coef­
ficients were calculated according to Svedberg and Katsurai (141). The
observed S values were corrected to s__ , the sedimentation coefficientzu,w
in water at 20*C according to Svedberg and Pedersen (142), and expressed
“X3
in seconds or Svedberg units (IS = 10 cgs. units).
Amino Acid Analysis 
Samples of apolipoproteins or polypeptides were dried over PgO^ 
under vacuum and then hydrolyzed in constant boiling HCl in an evacuated 
sealed tube at 110 +  1® for 24 and/or 72 hours. The hydrolysates were 
evaporated to dryness, redissolved in distilled water, and evaporated 
again to dryness. Solubilization of the residue in 3 ml of 0.2 N sodium 
citrate buffer (pH 2.2) was followed by filtration through a fine frit 
sintered glass filter. This solution was analyzed on a Beckman Model 
120C amino acid analyzer according to the accelerated procedure of Benson 
and Patterson (143) on spherical resins (Beckman Custom Spherical Resins,
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Typo l’A-28 for Llio noidio and neutral amino acids, and for the
basic amino acids). The analyzer was calibrated with a mixture of known 
amino acids. Half-cystine was determined as cysteic acid after oxidation 
of the apolipoproteins or polypeptides with performic acid. The values 
for cysteic acid were corrected for the 94% recovery found by Moore (144). 
Tryptophan was determined by the procedure of Gaitonde and Dovey (145).
Analysis of C- and N-terminal Amino Acids 
Carboxyl terminal analysis. Carboxypeptidase A (CPA) and/or 
carboxypeptidase B (CPB) were used for the enzymatic determination of 
the carboxyl terminal amino acids as described by Ambler (146). The pro­
tein sample was dissolved in 0.1 M N-ethylmorpholine (pH 8.5), and the 
CPA and/or CPB were added in the usual ratio of 1 part enzyme to 80 parts 
protein. In some cases the protein sample was heated in a boiling water 
bath before addition of the enzyme, or the reaction was run at a lower 
pH value (pH 6.5). Incubation of the enzyme-protein mixture was usually 
carried out at 37*C for varying time periods. A sample was withdrawn 
initially to serve as the blank, and the subsequent samples were taken 
at suitable time intervals after addition of the enzyme. The protein was 
precipitated with 6 N HCl, and the remaining supernate was evaporated to 
dryness. The residue was dissolved in 0.2 N sodium citrate, pH 2.2, and 
analyzed on the Beckman 12QC amino acid analyzer. Values obtained were 
corrected by subtraction of the blank levels of amino acids and contri­
butions from the autodigestion of CPA and/or CPB.
The carboxyl terminal amino acids were also determined with an­
hydrous hydrazine by the method of Braun and Schroeder (147).
Amino terminal analysis. Dansylation of the protein and/or
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peptide was carried out as described by Gray (148). After dansylation 
the protein was precipitated with 10% trichloroacetic acid (TCA) and cen­
trifuged at low speed to remove the excess reagents and by-products (149). 
The dansylated protein was then washed two times with 0.1 N HCl. Hydrol­
ysis of the dansylated protein with constant boiling 6 N HCl was carried 
out in an evacuated sealed tube for 18 hours at 110*C. Following hydrol­
ysis the ampule was opened and dried iai vacuo in the presence of NaOH 
pellets. The sample and standards were then spotted on a thin-layer 
plate coated with Silica Gel G and the dansyl amino acids were separated 
as described by Morse and Horecker (150).
Carbohydrate Analysis 
Sialic acid was determined by the thiobarbituric acid method 
(151). Samples were hydrolyzed with 0.1 N HCl for 1 hour at 80®. Neu­
tral sugars were analyzed by gas-liquid chromatography as alditol ace­
tates according to the procedure described by Kim et al. (152). Neutral 
sugars were released from the polypeptide preparations by hydrolysis 
with 1 N HCl for 4 hours at 100®. Galactosamine and glucosamine were de­
termined on the amino acid analyzer by comparison with the elution time 
of standards following hydrolysis of the sample with constant boiling 
6 N HCl for 24 hours at 110®C.
Lipid and Protein Analyses 
Lipid and protein analysis. Whole serum and various lipoprotein 
preparations dialyzed against 0.15 M  NaCl (pH 7.0) with 0.01% EDTA were 
utilized for lipid analysis. Free and total cholesterol were determined 
by the method of Schoenhlemer and Sperry (153). Cholesterol ester was
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calculated as cholesterol oleate. Lipid phosphorus was analyzed by the 
method of Fiske and Subbarow (154), after wet digestion by the procedure 
of Youngburg and Youngburg (155), or by the method of Gerlach and 
Deuticke (156). Lipid phosphorus was converted to phospholipid by multi­
plication with the factor 25. Triglyceride was measured either by the 
fluorometric method of Kessler and Lederer as applied to the auto-analyzer 
(157) or by the procedure of Van Handel and Zilversmit (158).
The analysis of individual phosphatides was performed on the 
organic extracts of totally delipidized lipoprotein fractions. The ex­
tracts were evaporated to dryness io vacuo at room temperature, and the 
residues were dissolved in chloroform. Phosphatides were separated by 
one (59) or two (3) dimensional thin-layer chromatography and visualized 
either with iodine or molybdenum blue (159). Quantitation of the phos­
phatides was achieved by scraping the individual spots off the plate and 
determining the phosphorus (156). The neutral lipids from the organic 
extracts were separated on silica gel G with petroleum etheridiethyl 
ether (90:10) and the spots were visualized either with iodine or by 
charring with sulfuric acid.
Protein was determined by the method of Lowry e^ ai^ . (160) , with 
human serum albumin as the standard.
Immunological Methods 
Immunodiffusion and immunoelectrophoresis. Double diffusion 
(161) and immunoelectrophoresis (162) were carried out on glass slides 
(25 X  75 mm) coated with 1% agar or agarose employing veronal buffer, 
pH 8 .6 , ionic strength 0.1. Immunoelectrophoresis was carried out at 
6.5 volts/cm for 60 minutes. A drop of 10% dextran was sometimes added
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to the center well of an immunodiffusion pattern to enhance the develop­
ment of precipitin lines. The precipitin patterns were allowed to de­
velop for 48-72 hours at ambient temperature, although they appeared to 
be satisfactory already after only 24 hours. Plates were washed in dis­
tilled water for 48 hours and then dried under a strip of lintless paper. 
A 1% Amido Black lOB or a 0.06% Coomassie Brilliant Blue in water:ethanol 
(55:45, w/v) solution was utilized for protein staining with the back­
ground stain removed with 10% acetic acid or 95% ethanol, respectively. 
Lipid staining was accomplished with Oil Red 0.
The optimal ratio of antibody to antigen for the absorption of 
either antibody or antigen was determined with the Micro-titer set (Cooke 
Engineering Co., Alexandria, Va.). Both antigen and antibody were di­
luted serially in 0.1 M  borate buffer, pH 8 .6 , and then the appropriate 
component was added. Plates were Incubated overnight at 37"C, and the 
optimal ratio was established by selecting the well displaying the maxi­
mal precipitation. Using this ratio, the undesirable antigen or antibody 
was removed by addition of the appropriate antibody or antigen, incuba­
tion of the reaction mixture for two hours at 37®C, and low-speed cen­
trifugation of the Immunoprecipitate. If necessary, the entire procedure 
was repeated to remove the last traces of either antigen or antibody.
Preparation of antibodies. Antigens for Injection were obtained 
from various sources. LP-A and Its two peptides were furnished by Dr.
G. Kostner; LP-X by Dr. D. Seidel and Dr. H. Magnanl; density classes 
and various ApoC preparations were prepared by the methods described. 
Prior to administration, lipoprotein, apollpoproteln, and polypeptide 
preparations were dialyzed against 0.9% NaCl In 0.1% EDTA. Equal volumes
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of antigen (protein concentration 0.5-10 mg/ml) and Freund's complete 
adjuvant were homogenized and then injected intraperitoneally into white 
New Zealand rabbits. Angora goats, or Black Kekule sheep. One or two 
additional injections via the same route, at intervals of ten days, were 
usually sufficient to elicit antibody titers adequate for our studies. 
Subsequent booster injections were used only when the titer of the anti­
sera became low as demonstrated either by immunodiffusion or immunoelec­
trophoresis against whole serum or corresponding lipoprotein preparations.
The drawing of blood from the immunized animals commenced two 
to three weeks following the initial immunization. Blood samples (35-40 
ml) were collected from the rabbits by cardiac puncture at weekly inter­
vals. An evacuated flask was utilized to draw blood from the jugular 
vein of the goats and sheep in a volume of 300 to 500 ml at intervals of 
2-3 weeks. The collected blood was allowed to stand at both room tem­
perature and 4“C to allow the clot to form and retract. The clot was 
removed by low-speed centrifugation, and the antisera were examined by 
immunodiffusion and/or immunoelectrophoresis against various antigenic 
lipoprotein preparations. When necessary, the antisera were treated with 
appropriate antigens to remove undesirable antibodies. The antisera, 
with sodium azide ( 1 mg/ml of antiserum) added as a preservative, were 
stored at -20“C.
Commercial antisera. Antisera prepared commercially were pur­
chased from Behrlngwerke AG (Marburg-Lahn, Germany). Antisera to the 
following human serum components were utilized in this study: albumin,
oi-lipoprotein, 6 i-lipoprotein, a 2 -lipoprotein, whole serum, yiA-globu- 
lin, y-globulin, oj-acid glycoprotein, a2-macroglobulin, transferrin.
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fibrinogen, y i~n>acroglobulin, 6 2 "6 lycoprotein, cerruloplasmin, IgA, IgM, 
IgG, C-reactive protein, and Bence-Jones K and A chain. Also, anti­
rabbit whole serum and y-globulin were purchased from Behrlngwerke.
CHAPTER IV
RESULTS
Antigenic Characterization of Density 
Lipoprotein Classes
Normal Fasting Plasma 
Normal fasting plasma was fractionated into the major density 
classes, each of which was examined for the presence of various lipopro­
tein families by Immunological and electrophoretic techniques. Double 
diffusion studies (Fig. 5a) demonstrated the presence of the following 
lipoprotein families: A-LP-A gave precipitin lines with LDL^, HDL^, HDL^,
and the 1.21 infranate; A-LP-C reacted positively with all density classes 
except the 1.21 infranate; A-LP-B gave precipitin lines with VLDL, LDL^, 
LDL^, HDLg, and occasionally with HDL^. Another precipitin line between 
HDLg and A-HDL^, closer to the antibody well, was always present in this 
high-density lipoprotein fraction (Fig. 5b). This antigenic component 
has been designated by Lee and Alaupovic (90) as the "thin-line" polypep­
tide. A double diffusion study of HDL^ (Fig. 5b) revealed reactions of 
non-identity between A-LP-A, A-LP-B, and A-LP-C.
Immunoelectrophoretic studies of the various density classes re­
vealed that VLDL and LDL^ gave similar precipitin lines of a 2 mobilities 
with antibodies to LP-B, LP-C, and WS. The LDLg showed a similar reactiv-
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anti-WS
anti-LP-A
anti-LP-C
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Figure 5. Immunodiffusion patterns of lipoprotein density 
classes from a normal female donor (pattern a) and a normal male donor 
(pattern b). Lipoproteins were placed in the central wells. V = VLDL, 
Li = LDL^, Lg = LDL2 , H 2 = HDL2 , H 3 = HDL3 . Outer wells contain anti­
bodies to whole serum (anti-WS); LP-A (A); LP-C (B); LP-B (C); IgG (D); 
albumin (E); whole serum (F); HDL3 (G); and VLDL (I).
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icy, but the mobility was slower, and the precipitin arc with A-LP-C was 
much weaker. The HDL^ fractions reacted with A-WS, A-LP-C, A-LP-B, and 
A-LP-A. Whereas the precipitin lines of LP-B and LP-C had similar mobil­
ities, the LP-A precipitin line was somewhat elongated, streaking through 
the « 1 and 0 .2 regions. The HDL^ gave precipitin arcs with A-WS, A-LP-C, 
and A-LP-A. The major LP-A precipitin arc migrated faster than that due 
to LP-C. Relative mobilities of density classes on paper and agarose 
electrophoresis were similar to those observed on Immunoelectrophoresis.
Examination of the basic polyacrylamide gel patterns of various 
density classes revealed characteristic patterns (Fig. 6 ). The VLDL iso­
lated from fasting plasma typically yielded three fast-moving bands when 
electrophoresed in the presence of 8 M urea but only two bands (C-III-1 
and C-III-2) in the absence of urea. The mobility of all bands was 
greater in the absence than in the presence of urea. A slower moving 
band was also observed occasionally in the separating gel. The loading 
and stacking gels, as well as the junctions between the three gels, were 
always stained with the protein stain. Similarly, the loading and stack­
ing gels were always stained for lipid. However, the two fast-moving 
bands were stained for lipid in only 50% of the VLDL samples examined.
The electrophoretic pattern of LDL was very similar to that of 
VLDL. Another faint band was occasionally noted midway between the fast- 
moving bands and the heavily stained region at the juncture of the sepa­
rating and stacking gels. Loading and stacking gels were always stained 
for both protein and lipid. However, the fast-moving bands were stained 
only for protein.
The HDLg and HDL^ patterns were similar except that the HDL^
o\
H 2 H3
Figure 6 . Basic polyacrylamide gel electrophoresis (PAGE) of lipoprotein density classes.
PAGE was run on 7% gels containing 8 M urea and stained with Amido Black. V = VLDL, L = LDL, H 2 = HDL2 , 
and H3 = HDL3 .
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sample usually showed no protein stained band at the junction of the sep­
arating and stacking gels. There were several protein stained regions 
between the juncture of the stacking gel and the fast-moving bands. Only 
the principal bands were stained intensively with Oil-Red-0; there was no 
lipid staining of the fast bands. A better resolution of the heavily 
stained bands was achieved with low concentrations of HDLg and HDL^, but 
the fast-moving bands were very faint or absent.
Immunochemical investigation of the patterns obtained on 7% 
polyacrylamide by imbedding the gels in agarose revealed certain charac­
teristic precipitin patterns. The LDL, HDLg, and HDL^ exhibited three 
regions of reactivity in the separating gels: the fast-moving bands re­
acted with A-LP-C, the junction of the separating and stacking gels with 
A-LP-B, and the intermediate region with A-LP-A. In some instances a 
reaction was observed with A-LP-C in the region immediately adjacent to 
the juncture of the separating gel. If LDL^ or LDL was examined in the 
same system, reactions with A-LP-B, A-LP-C, and A-LP-A were usually ob­
served in the loading and stacking gels.
Three percent polyacrylamide patterns of these three density 
classes were less complex when stained with protein or lipid stain, but 
there was no clear-cut separation of lipoprotein families. The faster 
moving band(s) reacted with both A-LP-A and A-LP-C while the slower moving 
zone reacted with A-LP-B and A-LP-C. Occasionally a reaction with A-LP-A 
was observed with the slower moving zone. The intermediate region re­
acted with both A-LP-C and A-LP-A while the stacking and loading gels 
had the same pattern of reactivity as the 7% gels.
As already mentioned, VLDL reacted with A-LP-B and A-LP-C and
68
very infrequently with A-Ll’-A. Since the LP-A antigenic component (s) 
was possibly buried in the VLDL molecule, the partially delipidized VLDL 
produced very faint precipitin lines with A-LP-A. It was concluded from 
these immunochemical studies that there is very little, if any, LP-A in 
the normal fasting VLDL. When VLDL was examined by double diffusion 
against A-LP-B and A-LP-C, a line of complete fusion was observed between 
these two antigen-antibody complexes (Fig. 7a). All VLDL samples gave 
at least one precipitin line with A-C-1, but some gave two distinct 
lines. Most VLDL preparations reacted positively also with A-C-111.
Immunoelectrophoretic analysis of various VLDL preparations on 
agarose gels revealed at least two lipoprotein bands with different mo­
bilities. The faster moving band reacted with antibodies to C-1, C-11, 
C-111, and LP-B, whereas the slower moving band gave precipitin arcs only 
with antibodies to C-11 and C-111 (Fig. 7b). The presence of a slow- 
moving band seems to suggest a partial dissociation from the VLDL com­
plex of C-11 and C-111 polypeptides or polypeptide-lipid units, but not 
C-1. Reaction of VLDL with antibodies to LP-B and C-1 resulted in a com­
plete fusion of precipitin arcs.
Presence of urea had a striking effect on the separability and 
mobility of various VLDL bands in 7% polyacrylamide gel electrophoresis 
at pH 8 .8 . In the absence of urea from gels, only two C-111 bands were 
clearly distinguished; however, when 4 M urea was incorporated into the 
loading gel, a third band corresponding to the C-11 polypeptide became 
much more prominent. A 20% decrease in the mobility of all the fast- 
moving LP-C bands was noted when 8 M urea was incorporated into the sepa­
rating gel. The LP-C bands present in LDL and HDL also showed this re-
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Figure 7. Immunodiffusion of VLDL from four normal subjects 
(pattern a) and immunoelectrophoresis in 1 % agarose gel of three differ­
ent normal VLDL samples (pattern b)• Anti-sera were placed in the outer 
wells. V = VLDL, A - anti-LP-A, B = anti-LP-C, and C = anti-LP-B.
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duction in mobility. In the acidic (pH 4.3) polyacrylamide system, the 
sharpest resolution of C-I was obtained when urea was present in all 
gels. Urea had no apparent effect on the mobility of this faint fast- 
moving band.
It was demonstrated by immunological examination of the VLDL 
bands separated by 3 or 7% polyacrylamide gel electrophoresis, pH 8 .8 , 
that they reacted positively with A-LP-C, A-LP-B, A-WS, and in a few 
cases, with A-LP-A. Reactions with A-LP-C, and A-LP-B were observed at 
the junction of the separating and stacking gels in both systesm (Fig. 8 ). 
In the 3% system the VLDL bands formed in the separating gel ("beta" and 
"post-beta" bands) reacted both with the antibodies to LP-B and LP-C 
(Fig. 8 a). In the 7% system the fast-moving bands in the separating gel 
gave precipitin lines only with antibodies to LP-C (Fig. 8 b).
Results of these studies showed that intact lipoproteins are 
separated by 7% polyacrylamide gel electrophoresis into three main zones. 
The fast-moving bands in the separating gel are those of LP-C; the in­
termediate region consists of LP-A bands; and the band at the juncture 
of the separating and stacking gels is LP-B. Lipoproteins retained in 
the loading and stacking gels represent a mixture of LP-A, LP-B, and LP-C 
species of the sizes and molecular weights characteristic primarily of 
VLDL or LDL^.
Chyle
Chyle samples obtained following a fat meal or dextrose-water 
were fractionated into VLDL, LDL and HDL. Testing by immunodiffusion 
demonstrated that LP-A was present in all density classes except the VLDL 
isolated during the glucose-water regimen; the LP-C was present in all
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anti-LP-C
anti-LP-B
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anti-C-IH
anti-LP-B
anti-LP-C
anti-LP-B
Figure 8 . Combined basic polyacrylamide gel electrophoresis and 
immunodiffusion of VLDL on a 3% gel (pattern a) and 7% gel (pattern b). 
Acrylamide gels were embedded in 1% agarose.
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donsiLy I’lassc's cxaniiiiL’tl. The hP-B was ahsent immiinuihomlca 1 ly from Lhe 
postprandial HDL in 2 of 3 different chyle samples examined*
The subfractionation of chyle into VLDL subclasses was performed 
only with a sample obtained following a high fat diet. The VLDL subfrac­
tion with Sj > 5,000 gave an indistinct halo rather than distinguishable 
precipitin lines with A-LP-A, A-LP-B, and A-LP-C. However the 400- 
5,000, Sj 20-400, LDL, and HDL all reacted with A-LP-A and A-LP-C. It 
seems that all of these density classes also contained LP-B.
Paper electrophoretic studies revealed that the postprandial 
chyle VLDL had a heavily lipid-stained region at the origin, while both 
VLDL and LDL displayed a lipid-stained band extending from the origin 
through the pre-beta region. All three density classes of the postpran­
dial chyle had an a^-band while the HDL had no Bi-band. The glucose- 
water VLDL displayed lipid staining from the origin to the pre-beta re­
gion while LDL and HDL both had bands in the Bj and oj region.
Agarose electrophoresis of VLDL demonstrated that the mobility 
of the postprandial sample extended from the origin through the pre-beta 
region while the glucose-water sample was characterized principally by 
the pre-beta band. The postprandial LDL resolved into three bands in the
0 2 -region. The sample from postprandial and glucose-water state revealed 
only a single oj band.
Disc gel electrophoresis of three VLDL subfractions, LDL, and 
HDL Isolated from postprandial chyle showed a similarity in their reso­
lution but a variation in the staining intensity of individual bands 
(Fig. 9). Whereas VLDL subfractions with 20-400 and 400-5,000 had 
several prominent bands in the LP-A region, the subfraction with >
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Figure 9. Basic polyacrylamide gel electrophoresis of post­
prandial chyle lipoproteins. PAGE was run on 7% gels containing 8 M urea 
and stained with Coomassie Brilliant Blue. = Sg 400-5,000, V3 = Sg 
20-400, L = LDL, and H = HDL.
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5,000 was characterized by one major and several minor bands in the same 
region. Similar faint bands in the LP-A zone were also seen in the LDL 
fraction. Although the HDL exhibited the highest staining density in the 
LP-A region, the bands were poorly resolved. Staining of the juncture of 
the separating-stacking gel, noted in the VLDL subfractions and LDL, was 
indicative of the presence of LP-B. The fast-moving LP-C bands were 
present in all density classes (Fig. 9).
Totally delipidized VLDL subfractions with S^ 400-5,000 gave 
positive immunoprecipitin lines with antibodies to A-I and A-II polypep­
tides (Fig. 10a). The A-I polypeptide separated from the totally delip­
idized chyle subfraction with S^ 400-5,000 by Sephadex G-lOO gel filtra­
tion and DEAE-cellulose chromatography showed immunochemical identity 
with the A-I polypeptide isolated from totally delipidized plasma HDL 
(Fig. 10b).
To obtain some information about the relative distribution of 
various LP-A and LP-C bands in three VLDL subfractions isolated from a 
postprandial chyle sample, the 7% polyacrylamide gels were stained with 
Coomassie Blue, and the bands in the separating gels were measured by 
densitometric scanning. The results presented in Table 9 do not include 
the LP-B band occurring at the juncture of stacking and separating gels 
and the LP-A, LP-B,and LP-C species present in the loading and stacking 
gels. Each lipoprotein band was characterized by its mobility relative 
to that of the principal fast-moving LP-C band (C-III-2) and by compari­
son of these mobilities with those of corresponding totally delipidized 
species. The scans revealed that the LP-A region accounted for approxi­
mately 85% (83-88%) and the LP-C region for about 15% (12-18%) of the
A-1 (Plasma) #  A-1 (Plasma)
A*I (Chyle) ^ •  A-I (Chyle) 3
Figure 10. Immunodiffusion (pattern a) of totally delipidized postprandial chyle subfraction 
Sf 400-5,000 (V2 ). Immunodiffusion of A-I polypeptide isolated from chyle VLDL subfraction (Sf 400- 
5,000) and plasma HDL. A = anti-A-I, B = anti-A-II, C = anti-C-III, and D = anti-C-I (pattern a); A = 
anti-A-I and B = anti-LP-A (pattern b).
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TABLE 9
RELATIVE CONTENT OF LP-A AND LP-C POLYPEPTIDES IN 
SUBFRACTIONS OF CHYLE VLDL
Band
Polypeptide
Designation
Chyle VLDL Subfractions^
S^ > 5,000 Sj 400-5,000 S. 20-400 f
% % %
A C-III-2 5.46 7.19 8.33 1 . 0 0
B C-III-1 3.85 3.13 5.08 0.926
C C-II 2.84 4.76 3.41 0.819
D A-peptide 3.44 5.97 5.76 0.764
E A-peptide 11.29 12.87 6.09 0.577
F A-peptide 30.58 31.23 19.36 0.465
G A-peptide 29.38 23.41 2 2 . 6 8 0.375
H A-peptide 13.16 11.43 29.28 0.228
A-C LP-C 12.15 15.08 17.82
D-H LP-A 87.85 84.92 83.18
a.
Determined by densitometric scanning of the separating gel, 
pH 8 . 8  in 8  M urea and expressed as percent of the sum of individually 
determined bands.
Average mobility of each band for three subfractions. The mo­
bility of C-III-2 was taken as unity.
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stained lipoprotein bands; the LP-C bands increased with a decrease in 
the S^-values of VLDL subfractions. The average ratio of the C-III-2 
band to the C-III-I band (R = 1.79) in the three VLDL fractions was simi­
lar to the ratio found with the C-III polypeptides from some preparations 
of ApoX.
To study the effect of diet on the relative distribution of LP-A 
and LP-C bands in 7% polyacrylamide gels, the VLDL, LDL, and HDL were iso­
lated from chyle samples collected from a patient during a prolonged fast, 
after a high-fat meal, and on a diet consisting of only dextrose and
water. Results of densitometric evaluation of the LP-A and LP-C bands of
major lipoprotein density classes are presented in Table 10. Diet had
very little effect on the relative distribution of LP-A and LP-C bands in
HDL. On the other hand, dietary fat had an appreciable effect on the 
distribution of LP-A and LP-C in VLDL; with an increased fat-load, there 
was an increase in the relative content of LP-A and a decrease in the 
content of LP-C. The densities of bands in the stacking and loading gels 
and of the LP-B band were not estimated.
A sample obtained by cannulation of the right thoracic duct was 
compared to a sample drawn at the same time from the left thoracic duct 
The chyle from the right thoracic duct showed on immunoelectrophoresis 
positive reactions with A-LP-A, A-LP-B, and A-WS but not with A-LP-C 
(Fig. 11). On double diffusion the only difference noted between the 
two chyle samples was that the chyle from the right thoracic duct did 
not react with A-LP-A. The ultracentrifugation of the chyle from the 
right thoracic duct at d 1.006 g/ml demonstrated the absence of a VLDL 
class. However, the 1.006 infranate reacted with both A-LP-B and A-LP-A.
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TABLE 10
THE EFFECT OF DIET ON THE RELATIVE CONTENT OF LP-C AND 
LP-A IN THE MAJOR DENSITY LIPOPROTEIN 
CLASSES OF CHYLE
Diet Density Class
Lipoprotein®
LP-A LP-C
75% Fat VLDL
%
72.99
%
27.00
LDL 81.12 18.18
HDL 81.57 18.43
Fasting VLDL 33.81 66.19
LDL 77.88 2 2 . 1 2
HDL 86.69 13.31
Dextrose-Water VLDL 32.53 67.47
LDL - —
HDL 82.31 17.68
a.
Determined by densitometric scanning of the basic separating 
gel in 8 M urea.
anti-LP-A
anti-LP-B
anti-WS
anti-LP-C
Figure 11. Immunoelectrophoresis in 1% agarose gel of right thoracic duct chyle. A = right 
thoracic duct chyle.
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It was concluded from these studies that the chyle isolated from the 
right thoracic duct had very little, if any, VLDL and LP-C.
Plasma from Hypertriglyceridemic Patients 
The qualitative apolipoprotein composition of VLDL, LDL, and HDL 
isolated from plasma samples of patients with type I, III, IV, and V hy­
pertriglyceridemia was determined by examining the intact lipoproteins 
with immunological methods and 7% polyacrylamide gel electrophoresis. 
Results of these studies (Table 11) showed that neither dietary regimen 
nor the type of lipid transport derrangement had any effect on the qual­
itative distribution of LP-B and LP-C; these two lipoprotein families 
were detected in all density classes of hypertriglyceridemic patients. 
Similarly, the LP-A family was detected in HDL of all hypertriglyceridemic 
patients. However, the LP-A was positively identified only in VLDL iso­
lated from Types I and V but not in VLDL from Types III and IV. The LP-A 
could not be detected in intact LDL. In hypercholesterolemic (Type II) 
patients the LP-B and LP-C were positively identified in VLDL and LDL 
whereas HDL was not examined.
The analytical polyacrylamide patterns demonstrated that C-I, 
C-II, and C-III polypeptides were present in the VLDL of all Type I, III, 
IV, and V hypertriglyceridemic patients.
Although the dietary fat had little effect on the qualitative 
composition of apolipoproteins in major density classes, an increased 
fat intake seems to influence considerably the absolute levels as well 
as the percent distribution of lipoprotein families or their protein 
moieties in at least VLDL and LDL. Preliminary results of such a study 
with a Type III hypertriglyceridemia patient showed not only a marked
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TABLE 11
DISTRIBUTION OF APOLIPOPROTEINS IN THE MAJOR LIPOPROTEIN 
DENSITY CLASSES ISOLATED FROM PATIENTS WITH VARIOUS 
TYPES OF HYPERTRIGLYCERIDEMIA
Hypertriglyceridemia Dietary
regimen
Density
Class
Apolipoproteins 
ApoA ApoB ApoC
Type I Fasting VLDL + + +
40% fat diet LDL - + +
HDL + + +
Type III Fasting VLDL - + +
Non-fat diet LDL - + +
HDL + + +
Fasting VLDL - + +
40% fat diet LDL - + +
HDL + + +
Type IV Fasting VLDL - + +
40% fat diet LDL - + +
HDL + + +
Fasting VLDL - + +
75% fat diet LDL - + +
HDL + + +
Type V Fasting VLDL + + +
40% fat diet LDL - + +
HDL + + +
Six hours VLDL + + +
after a LDL - + +
high-fat diet HDL + + +
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increase in the absolute amounts but also a redistribution of LP-C and 
LP-B families in VLDL and LDL. However, the number of patients studied 
is still too small to permit a more thorough evaluation of the signifi­
cance of these results.
Tissue homogenate studies of intestinal mucosa and liver obtained 
from recently deceased (3-4 hours) human cadavers were examined by immuno­
diffusion. Reactions with A-LP-C were obtained in three of four intes­
tinal mucosal samples examined; and, in two samples, two precipitin arcs 
were present, one of which apparently fused with a precipitin line pres­
ent in a whole serum that contained LP-X. A-LP-A precipitin arcs were 
observed only when the A-LP-A was diffused against whole serum, while 
faint precipitin lines were observed when A-LP-B was diffused against 
both the liver and intestinal homogenates of one subject.
Antisera
Random plasma, fasting plasma, and postprandial plasma were uti­
lized as the sources of antigens which were isolated either as intact 
lipoproteins or as apolipoproteins. The antisera were characterized by 
immunodiffusion and immunoelectrophoresis against whole serum, density 
classes, or purified polypeptides. The reactions of all antisera with 
whole plasma were comparable on agar and agarose gels except that the 
mobilities of antigens were reduced on agar gels. The characteristics 
of antisera obtained against major density classes are presented in 
Table 12. Antisera to fasting (VLDL) and postprandial VLDL (PP-VLDL) 
differed only in that the latter contained antibodies to LP-A. Some 
HDLg antisera contained antibodies not only to the two ApoA polypeptides 
but also to a polypeptide referred to as the "thin-line" polypeptide (90).
TABLE 12
CHARACTERIZATION OF ANTISERA TO ULTRACENTRIFUGALLY ISOLATED 
LIPOPROTEIN DENSITY CLASSES
Designation of Host
Total
protein
injected
Specificity
Comment
antisera animal
LP-A LP-B 1LP-C
A-VLDL Rabbit 3-8 mg + + Fasting normal VLDL was the source of 
antigen (pool of five subjects).
A-PP-VLDL Rabbit 5-15 mg + + + Postprandial hypertriglyceridemic VLDL 
(Type V) was the source of antigen.
A-LDL Rabbit 5-16 mg + - One of seven A-LDL*s reacted with LP-X 
on agar immunoelectrophoresis.
A-HDLg Rabbit 1 0 - 2 0  mg + 4" + Three of six A-HDL-'s also contained 
antibodies directed against the "thin- 
line" polypeptide.
Co
u>
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Table 13 shows the source and reactivity of antisera directed against 
purified lipoprotein families and the polypeptides of ApoA and ApoC.
Examination of immunoelectrophoretic patterns of plasma samples 
from normal subjects and patients with obstructive jaundice revealed some 
characteristic precipitin arcs when they were tested with various anti­
sera. Whereas antibodies to C-I gave a similar anodal precipitin arc 
with both normal and jaundiced plasma, the typical cathodal arc (LP-X) 
was formed only with the jaundiced plasma (Fig. 12a). Reaction between 
the antibodies to LP-B and normal or jaundiced plasma samples resulted 
in the formation of identical precipitin arcs which extended from the 
well into the gj-region (Fig. 12b). Both plasma samples also gave essen­
tially the same pattern with A-LP-A; it consisted of two converging pre­
cipitin arcs with a spur between them (Fig. 12c),
The cathodal mobility of LP-X was very useful as a test for the 
possible presence of antibodies to LP-C in various antisera. When tested 
against jaundiced plasma, most antisera to VLDL, several antisera to HDL, 
all A-LP-X, and one antiserum to LDL displayed the typical cathodal mi­
gration indicating the presence of antibodies to LP-C.
Column Chromatography and Precipitation Methods 
In an attempt to separate lipoprotein families, especially LP-C, 
the major density classes were chromatographed on several different media.
Ion exchange chromatography of lipoprotein density classes on 
DEAE-cellulose, with or without 8  M urea, was only partially successful. 
There was no resolution of either the VLDL or LDL. However, the HDL^ 
was separated into four peaks with a NaCl linear gradient (0.01 M - 
0.5 M, pH 7.2 40 cm column). An antiserum prepared by immunizing rabbits
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TABLE 13
CHARACTERIZATION OF ANTISERA TO LIPOPROTEINS AND POLYPEPTIDES
Designation
of
antisera
Host
animal
Total
protein
injected
Method of preparation of antigen
A-LP-A Goat 40 mg Phosphotungstate precipitation (ppt. 
II), ultracentrifugation (1.12-1.21 
g/ml) and hydroxyapatite
A—A—I Sheep 23 mg Column chromatography of ApoA
A-A-II Sheep 2 0  mg Column chromatography of ApoA
A-LP-B Rabbit 5-16 mg Ultracentrifugally isolated LDL
A-LP-C Rabbit 5.0 mg Partial delipidization of LP-X follow­
ed by ultracentrifugation
A-C-I Rabbit 1 0  mg DEAE-cellulose chromatography
A-C-'Ab Rabbit 1 0  mg
Partial delipidization of LP-X follow­
ed by ultracentrifugation
A-C-II Rabbit 2 . 0  mg DEAE-cellulose chromatography followed 
by polyacrylamide gel electrophoresis 
(PAGE)
A-C-I, II Sheep 1 0  mg Preparation of LP-X
A-C-III Rabbit 5.0 mg DEAE-cellulose chromatography followed 
by PAGE
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TABLE 13— Continued
Specificity
Comment
A-I A-II B C-I C-II C-III
+ + Absorption of A-albumin and A-LP-B.
+
+ Titer to unknown component which may 
be due to a polymorphic form of A-II.
+
+ + +
+ Absorption of A-albumin
+ Absorption with HDL^. Titer to an un­
known component present.
+
+ +
+
Absorption with 1.25 g/ml infranate and 
LDL •
One of the two A-C-III may contain an 
additional antibody directed against 
C-III-3.
AB
A
B
A
B
anti-C-I
anti-LP-B
00
anti-LP-A
Figure 12. Immunoelectrophoresis in 1% agar gel of whole plasma. A = obstructive jaundiced 
plasma and B = normal fasting plasma.
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with the second peak reacted only with A-I and A-II polypeptides. The 
parent HDL^ also produced antibodies to LP-B and, possibly, LP-C.
Column chromatography on Sephadex G-200, Sepharose 43, and 
Sepharose 63 was utilized in an attempt to separate the lipoprotein fam­
ilies present in the various density classes. Sephadex G-200 was found 
to be unsatisfactory for separating LP-A, LP-3, LP-C, and the density 
classes because the larger lipoproteins (those in VLDL and LDL) were 
eluted in the void volume. In fact, none of the molecular seive media 
could be successfully applied to the resolution of lipoprotein families 
in the VLDL, LDL, or HDL as judged by immunodiffusion and disc gel elec­
trophoresis. However, the VLDL, LDL, and HDL were resolved by Sepharose 
63 or 43 into three peaks. The VLDL eluted before the major Blue Dextran 
peak exhibited some trailing (Fig. 13) while the LDL was resolved into 
a major peak eluted immediately after Blue Dextran and into a minor late 
peak which was not identified immunologically. The HDL (1.063-1.21 g/ml) 
was eluted as two discernible peaks, the first of which consisted of a 
mixture of LP-3 and LP-C and the second, principally, of LP-A. Each of 
the three major peaks corresponding to VLDL, LDL, and HDL were identi­
fied, in order of elution, as LP-B and LP-C, LP-3 and LP-C, and LP-A and 
LP-C, respectively.
Attempts to resolve VLDL by hydroxylapatite column chromatog­
raphy into LP-C and LP-B families were not successful. On the other hand, 
some separation of LP-C from LP-A was achieved when HDL^ was used as the 
starting material with LP-C eluted primarily with 0.25 M and 0.40 M phos­
phate buffer (pH 6 .8 ).
Heparin precipitation, phcsphotungstate, ethanol-water, and poly-
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Figure 13. Elution pattern of VLDL, LDL and HDL from Sepharose 
Lipoproteins were eluted with 0.1 M borate buffer (pH 8 .6 ).
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ethylene glycol precipitation of VLDL yielded no separation of LP-H from 
LP-C as determined by immunodiffusion.
Isolation of Partially Delipidized LP-C 
The scheme for isolation of pdLP-C by immunoprécipitation was 
outlined in Figure 3. The partially delipidized lipoprotein C from chyle 
and serum obtained after the immunoprécipitation procedure and removal 
of the rabbit serum proteins was tested by immunodiffusion, immunoelec- 
trophoresis, and basic disc gel electrophoresis. The pdLP-C gave a neg­
ative reaction on immunodiffusion with A-LP-A, A-LP-B, or any other of 
the commercially available antisera listed under the immunochemicaJ pro­
cedures. The pdLP-C reacted positively with both A-LP-C and A-VLDL with 
fusion of the two precipitin lines (Fig. 14a). On Immunoelectrophoresis 
the pdLP-C usually gave a single precipitin arc with A-LP-C and/or A-VLDL 
(Fig. 14b); however, in some cases pdLP-C gave two precipitin arcs with 
A-LP-C (Fig. 14b). On disc gel electrophoresis the pdLP-C consisted of 
four fast bands (Fig. 15a). Unfortunately, the A-HDL^ utilized for im­
munoprécipitation was found to contain a weak titer for LP-C, and there­
fore this approach for the isolation of partially or totally delipidized 
LP-C was abandoned.
For the above reason the ultracentrifugal isolation of partially 
delipidized C was developed (Fig. 4). Both postprandial VLDL from hyper­
lipemia patients and postprandial chyle lipoproteins (S^ > 1 0 0 ) were 
utilized as the starting material. The two fractions isolated by the 
ultracentrifugal procedure (Fig. 4) were designated as Fraction C (d 1.04- 
1.12 g/ml) and Fraction ABC (d 1.12-1.21 g/ml). Fractions C and ABC re­
acted with antibodies to LP-C and VLDL while only Fraction ABC reacted
4pdLP-C
pdLP-C
pdVLDL
pdLP-C
anti-LP-C
anti-VLDL
VO
Figure 14. Immunodiffusion and immunoelectrophoresis of pdLP-C isolated by immunoprécipitation. 
pdLP-C was placed in central well (pattern a). Outer wells contain antibodies to LP-A (A); VLDL (B),
LP-C (C); LP-B (D); whole serum (E); and albumin (F).
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1
Fr. C Fr. C 
(Chyle) (Plasma)
Fr. ABC
Figure 15. Basic polyacrylamide gel electrophoresis and immuno­
diffusion of pdLP-C obtained by ultracentrifugation. The 7% acrylamide 
gels were stained with Coomassie Brilliant Blue (pattern a). Fr. C 
(d = 1.04-1.12 g/ml) and Fr. ABC (d = 1.12-1.21 g/ml) were placed in the 
central wells (pattern b). Outer wells contain antibodies to LP-A (A); 
VLDL (B); LP-C (C); LP-B (D); whole serum (E); and albumin (F).
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with A-LP-A and A-LP-B (Fig. 15b). The basic polyacrylamide pattern of 
partially delipidized lipoprotein C isolated from both chyle and serum 
(Fig. 15a) again had three to four fast-moving bands.
The ultracentrifugal pattern of pdLP-C preparations isolated
from both chyle and serum revealed single symmetrical sedimenting peaks
with s of 7.56 and s° 8.5, respectively (Fig. 16).
w , 2 0  w , 2 0
The pdLP-C from chyle and serum migrated on paper electrophore­
sis into the oj-region (Fig. 17). On agarose electrophoresis the pdLP-C 
band had a S-ci2 mobility and stained with both protein and lipid stains.
The pdLP-C obtained by both immunoprécipitation and the ultra­
centrifugal procedure was totally delipidized, and the ApoC was used for 
further studies. The phospholipid to protein ratio of pdLP-C was approx­
imately two. Kinetic studies with carboxypeptidase A revealed that ala­
nine was the principle C-terminal amino acid released from both serum 
and chyle ApoC (Table 14). Serine and threonine were the N-terminal 
amino acids for both chyle and serum ApoC.
Thin-layer chromatography of lipid extracts of pdLP-C demon­
strated the presence of cholesterol, cholesterol esters, triglycerides, 
and phospholipids. The average phosphatide composition of the serum and 
chyle pdLP-C (Table 15) had some dissimilarities in that the chyle pdLP-C 
had a lower relative content of sphingomyelin and a higher percent of 
phosphatidylethanolamine than the serum.
Isolation, Fractionation, and Characterization
of ApoC
Due to the tedious and time consuming procedures involved in 
preparing partially delipidized LP-C, it was decided to utilize totally
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Figure 16. Sedimentation pattern of plasma and chyle pdLP-C. 
Plasma pdLP-C (pattern a) was run at 44,770 rpm with photographs taken 
at 36 and 40 minutes. Chyle pdLP-C (pattern b) was run at 52,640 rpm 
with photographs taken at 24 and 32 minutes.
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f
Origin
pdLP-C
WS
Figure 17. Paper electrophoresis of pdLP-C. Papers were stained 
with Oil Red 0. WS = normal fasting serum.
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TABLE 14
CARBOXYL-TERMINAL ANALYSIS OF ApoC
Amino Acids
Time
1 ' 1 0 ' 30' 2 hrs 5 hrs 24 hrs
Alanine 5.70 6.76
ymoles/mg x 1 0 % 
6.65 7.40 7.41 8 . 1 1
Valine 2.30 3.37 3.27 3.25 3.61 3.70
Glycine 0.50 1 . 0 2 0.83 0.74 0.51 0.92
Serine 0.18 0.85 0.73 0 . 8 8 0.83 0.94
Time-study was performed with carboxypeptidase A.
TABLE 15
PHOSPHATIDE COMPOSITION OF PARTIALLY DELIPIDIZED LP-C FROM PLASMA AND CHYLE
Source
Lysophatidyl-
choline
Phosphatidyl-
inositol
Phosphatidyl­
choline
Sphingo­
myelin
Phosphatidyl­
ethanolamine
Reference
% % % % %
Chyle (6 )* 6 . 6  
(1.7 -20.8)
1 . 1 0
(0 -2 .0 1 )
73.9
(70.0-79.7)
5.40 
( 2 .0 - 8 .2 )
12.36
(2.6-15.8)
Plasma (6 )^ 10.74
(2.94-26.8)
1.81
(0-5.33)
63.43
(40.0-79.8)
15.75 
( 9.3-26.18)
6.64
(2.9-20.1)
pdLP-C 1 0 . 8 - 57.0 26.9 5.3 (3)
pdLP-X 2 . 6
(2 .6 )
- 75.0
(71.4-78.5)
2 2 . 6
(20.8-24.4)
1 . 2  
(0.7- 1.6)
(163)
^Number of determinations.
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delipidized plasma or chyle VLDL as a source for the isolation of ApoC.
The introduction of the phosphotungstate procedure (41) as a preparative 
method for the isolation of large quantities ot lipoproteins was found 
to be very satisfactory. Fractionation (Fig. 2) of the precipitate I re­
sulted in the separation of VLDL (d < 1.030 g/ml) and LDL (1.03-1.07 
g/ml), and the centrifugation of precipitate II yielded HDL (p < 1.23 
g/ml). Immunodiffusion and disc gel patterns revealed that LP-C was 
present in all three fractions, LP-B in VLDL and LDL, and LP-A only in 
the HDL (Fig. 18). Unfortunately, albumin was not removed from the HDL 
by repeated washes in the ultracentrifuge.
All three fractions (VLDL, LDL, and HDL) obtained by phospho­
tungstate precipitation as well as VLDL isolated by ultracentrifugation 
and pdLP-C prepared by immunoprécipitation procedure were utilized, after 
total delipidizatlon, as a source of ApoC.
The totally delipidized material from VLDL and LDL preparations 
dissolved in various solvents (see the section on Methods) and that from 
HDL soluble in aqueous buffers were chromatographed on Sephadex G-75 or 
G-lOO columns equilibrated with either O.IM (NH^)2 C0 g or 2M CH^COOH. A 
typical elution pattern of a soluble apoVLDL preparation chromatographed 
on a Sephadex G-lOO column and the polyacrylamide gel patterns of each 
major eluate indicated clearly the protein heterogeneity of this density 
class (Fig. 19a). Each fraction was characterized by polyacrylamide geJ 
electrophoresis (Fig. 19b), immunodiffusion, and Immunoelectrophoresis 
(Fig. 20a and b). Fraction 1 consisted of ApoA, ApoC, and albumin and 
was thought to be an aggregated protein complex while fraction 2 contain­
ed A-I, albumin, and ApoC. Analysis of fraction 3 indicated that it was
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Figure 18. Immunodiffusion and basic polyacrylamide gel elec­
trophoresis of lipoproteins isolated by phosphotungstate precipitation 
and ultracentrifugation. PAGE was run on 7% gels with 8 M urea and 
stained with Coomassie Brilliant Blue. V = VLDL (d < 1.030 g/ml),
L = LDL (d 1.030-1.073 g/ml), and H = HDL (d < 1.23 g/ml) were placed in 
central wells. Outer wells contain antibodies to LP-A (A); LP-C (B); 
VLDL (C); LP-B (D); whole serum (E); and albumin (F).
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Figure 19. Elution profile of soluble apo-VLDL from Sephadex 
G-lOO (pattern a) and basic PAGE of the fractions eluted from the Sepha­
dex G-lOO run (pattern b). Numbers 1 through 6 correspond to Sephadex 
G-lOO fractions. The PAGE was run in 7% gels in 8  M urea and stained 
with Coomassie Brilliant Blue. Elution buffer for chromatography was 
0.1 M (NH4)2C03 (pH 9.0).
HHa 
anti A l
1
anti-LP-C
anti-LP-C
Figure 20. Immunodiffusion and immunoelectrophoresis of fractions (1-6) eluted from the Sepha­
dex G-lOO column (Figure 19a). Antisera were placed in the central wells. Immunoelectrophoresis was 
run in 1% agar. H 3 = HDL3 .
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an intermediate fraction. Fractions 4 and 5 consisted of the ApoC pep­
tides and were utilized for further fractionation of ApoC. The last 
traction (fraction 6 ) gave no precipitin lines with any antisera, no 
bands on disc gel and had less than 5% amino acids. Its further study 
was not pursued. Although the imraunoelectrophoretic precipitin arcs of 
ApoC were formed in fractions 1, 2, 4, and 5, the highest concentration 
of ApoC was found in fraction 4 (Fig. 20b). The number of fractions and 
their immunological and disc gel electrophoretic characteristics were 
similar for all soluble apoVLDL's examined with the exception that the 
first fraction (fraction i) was usually more prominent and had discern­
ible ApoC bands on basic disc gel. Extraction of this fraction with 
ethanol-ether, followed by rechromatography, usually resulted in recovery 
of an additional quantity of ApoC.
Column chromatography of ApoHDL on Sephadex G-75 gave a similar 
elution pattern except that the fractions 1 and 2 were greatly increased 
due to the presence of A-1 and A-11 peptides, respectively. The ApoC 
peak was eluted in a volume similar to that of ApoC from VLDL, but it was 
necessary to rechromatograph this fraction (fraction 4) to free it from 
some contaminating A-11 peptide.
Soluble portions of totally delipidized chyle VLDL (S^ > 100) 
and apolipoprotein X chromatographed on Sephadex columns gave elution 
patterns similar to those obtained with soluble apoVLDL. Fusion of im- 
munoprecipitin lines demonstrated a marked immunological similarity, if 
not identity, of ApoC preparations isolated from chyle, apoHDL, ApoX, and 
apoVLDL (Fig. 21a). Polyacrylamide patterns of these ApoC preparations 
were similar with respect to the fast-moving bands (Fig. zio). in some
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anti-LP-C anti-LP-C
anti-VLDL anti-VLDL
I
Figure 21. Immunodiffusion and basic PAGE of ApoC from various 
sources. The 7% gels were run in 8 M urea and stained with Coomassie 
Brilliant Blue. 1 = ApoC from LP-X, 2 = ApoC from VLDL, 3 = ApoC from 
HDL, 4 = ApoC from chyle, and V = VLDL.
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ApoC preparations, such as those from HDL or LP-X (Fig. 21b), the slow- 
moving bands could not be visualized by protein staining; however, other 
ApoC preparations from the same sources contained the slow migrating 
bands. The ApoC peak from chyle had several bands in the ApoA region 
which were not identified.
The residual protein components remaining after removal of the 
soluble portions of totally delipidized lipoprotein preparations were 
found to be soluble in 50% acetic acid. Chromatography of protein resi­
due on Sephadex G-75 or G-lOO equilibrated with 50% acetic acid yielded 
an asymmetrical elution peak which came off the column immediately after 
the void volume as determined with Blue Dextran. The finding of a small 
ApoC fraction in only one out of four fractionation experiments indicated 
that ApoC had been removed almost quantitatively during the solubiliza­
tion of delipidized lipoprotein preparations.
Isolation of lipoproteins from ten liters of random plasma by 
the phosphotungstate precipitation method yielded approximately 1 0  grams 
of total protein. The ApoC amounted to 600 mg, or 5-10% of the total 
lipoprotein protein. It was also estimated that lipoproteins with d < 
1.03 g/ml contained approximately 10% ApoC and HDL contained 5-6% ApoC. 
The highest amount of ApoC (35% of the total protein) was isolated from 
VLDL of a type III patient.
The basic disc gel pattern of ApoC clearly indicated that the 
protein moiety consisted of several polypeptides (Fig. 22a). Two groups 
of polypeptides are distinguishable: the fast-moving bands (C-II and
C-III) and the slow-moving, less distinct bands (C-I). To characterize 
the ApoC bands by their migration rates, the mobility of C-III-2 was
C-IlJ-0
c-rn-1
c-ni-2
cm-3
c-ra-4
A-I 
A-n
C-ffl-l 
C’III“2
o
Ul
Figure 22. Identification of ApoC and ApoA polypeptides on basic PAGE. The 7% acrylamide gels 
in 8 M urea were stained with Coomassie Brilliant Blue, a = ApoC from V L L u and b = ApoHDL.
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taken as unity, and the Rf-values of the other fast-moving bands were cal­
culated (Table 16). The Rf-values for C-I polypeptides were not calcu­
lated because the bands seen on basic disc gel were not sharply resolved. 
Since the ApoHDL was resolved into two distinct regions (Fig. 22b), one 
of which was characterized by the slow-moving bands (A-I and A-II) and the 
other by the fast-moving ApoC polypeptides (C-II and C-III), the Rf-values 
of A-I and A-II were also calculated on the basis of the mobility of 
C-III-2 taken as unity (Table 16).
A semi-quantitative determination of the principal ApoC polypep­
tides was made by scanning their band patterns on acidic and basic poly­
acrylamide gels (Table 17) and by determining the absorption at 260 my 
of the principal peaks eluted from DEAE-cellulose columns (Table 18).
The high percentage of C-I from the polyacrylamide scans probably re­
flected the high affinity of Coomassie Brilliant Blue for basic polypep­
tides. Variability in the composition of the ApoC polypeptides seen in 
Table 17 may reflect either selective losses during isolation of ApoC, 
non-linear dye uptake by the various polypeptides, or variability in the 
composition of ApoC. This variability has been demonstrated by gel scans 
of ApoC from LP-X, plasma VLDL, and plasma HDL^ which indicated that the 
ratio (R) of C-III-2 to C-III-1 was less than one for ApoC from VLDL 
(R = 0.856) and HDL^ (R = 0.798) but greater than one for ApoC from LP-X 
(R= 1.134). The ratio of C-III-2 to C-III-1 in VLDL subfractions from 
chyle was similar to that of LP-X.
Results of immunological and disc gel electrophoretic character­
ization of various ApoC preparations demonstrated a marked polypeptide 
heterogeneity of this apolipoprotein. To Isolate Individual polypeptides.
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TABLE 16
RELATIVE MOBILITIES OF POLYPEPTIDES OF ApoC AND ApoA ON BASIC 
POLYACRYLAMIDE GEL ELECTROPHORESIS IN 8 M UREA
Polypeptide Rf
ab
C-III-4 1.129
C-III-3 1.060
C-III-2 1.000
C-III-1 0.918
C-III-0 0.829
C-II 0.800
A-II 0.547
A-I 0.426
JOS
TABLE 17
RELATIVE CONTENT OF ApoC POLYPEPTIDES*
Polypeptide
Acidic
System
Basic
System
% %
C-I (1-3) 40.28 39.90
C-II 17.18 18.91
C-III-1 24.18 16.50
C-III-2 18.36 13.95
C-III-3 1 2 . 0 2
^Determined by densitometric scanning of ApoC bands on 
acidic and basic acrylamide gels in 8 M urea. Expressed as percent of 
the sum of individually determined bands.
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TABLE 18
RELATIVE CONTENT OF ApoC POLYPEPTIDES*
Polypeptide VLDL HDL
% %
C-I (1-3) 21.40 11.30
C-II 5.32 15.52
C-III-1 44.20 35.24
C-III-2 27.20 27.06
C-III-3 1.91 11.78
^Determined by absorption (260 mp) of peaks eluted from DEAE- 
cellulose chromatographic run. Expressed as percent of the sum of in­
dividually determined peaks.
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the ApoC was submitted to several fractionation procedures including 
DEAE-cellulose column chromatography, isoelectric focusing, and prepara­
tive polyacrylamide gel electrophoresis.
The DEAE-cellulose exchange chromatography was carried out with 
a concave gradient in the presence of 8 M urea. A typical elution pattern 
(Fig. 23) obtained with ApoC from \'LDL usually revealed three major and 
several minor fractions. An additional fraction eluted with 2 M acetic 
acid gave no immunochemical reaction or disc gel pattern and was not stud­
ied further. Similar elution patterns were also obtained with ApoC iso­
lated from chyle or apoHDL. Each fraction was tested by disc gel elec­
trophoresis and in some cases by immunoelectrophoresis. Although the 
polyacrylamide gel electrophoresis showed that most fractions were still 
heterogeneous (Fig. 24), chromatography on DEAE-cellulose resulted at 
least in a partial separation of ApoC polypeptides.
Since analytical isoelectric focusing revealed separate bands 
in each major fraction from the DEAE-cellulose column, the separation of 
the more acidic ApoC polypeptides was attempted on the smaller prepara­
tive Ampholine column (110 ml). From a single run on Ampholine (pH 5-7) 
in the presence of 8 M urea, the isoelectric points of several of the 
ApoC polypeptides were determined (Table 21). Unfortunately, an adequate 
separation was not obtained when a preparative run on the larger column 
(440 ml) was made with Ampholine (pH 4-6) even after refocusing of se­
lected fractions on the smaller column. For this reason, isoelectric 
focusing was abandoned as a possible preparative method for the isolation 
of the various ApoC polypeptides.
The separation of ApoC polypeptides by preparative polyacryl-
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Figure 23. Elution pattern of ApoC from a DEAE-cellulose column. Chromatography was carried 
out in phosphate - 8 M urea buffer (pH 7.2) with the NaCl gradient indicated by the dashed line.
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Figure 24. Basic PAGE patterns of fractions separated by DEAE-cellulose column chromatography 
of ApoC. The 7% acrylamide gels in 8 M urea were stained with Coomassie Brilliant Blue. Numbers 1 
through 6 correspond to fractions from DEAE-cellulose chromatogram (Figure 23). V = VLDL.
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amide electrophoresis was examined utilizing both the basic and acidic 
systems. A typical elution pattern (Fig. 25a) obtained by monitoring the 
absorbance at 280 mp usually consisted of one peak with some indication 
of shoulders. The examination of this peak by disc gel electrophoresis 
revealed regions of polypeptide homogeneity (Fig. 25b). The separation 
on the basic system was found to be satisfactory, while that obtained on 
the acidic was not reproducible. Separations were most satisfactory when 
only two components were to be separated. Preparative polyacrylamide 
gel electrophoresis with a basic buffer system resolved successfully the 
fast-moving ApoC bands into homogeneous polypeptides. Results of these 
studies have shown that the C-III polypeptides consist of at least five, 
and the C-II polypeptide of possibly two polymorphic forms.
Immunochemical Properties of the Various 
Purified Polypeptides of ApoC
The immunoelectrophoretic pattern of the fastest moving bands 
comprising the C-III group of polypeptides was compared with their pat­
tern on basic disc gel electrophoresis (Fig. 26). It was found that the 
mobilities of C-III-0 to C-III-3 on disc gel correlated well with the 
corresponding mobilities on agar gels (Fig. 27); in both supporting media 
the anodal migration increased progressively from C-III-0 to C-III-3.
The C-II polypeptide moved on polyacrylamide gel at a slightly 
slower rate than the C-III-0 polypeptide (Figs. 26, 28) and had an elec­
trophoretic mobility of 6 2 “globulin on agar (Fig. 27) and 8 j-globulin on 
agarose immunoelectrophoresis. Another band, designated C-II-0, moving 
slightly slower (Fig. 28) than the C-II polypeptide, was isolated in 
quantities insufficient for further characterization.
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Figure 25. Preparative basic PAGE elution profile (pattern a) 
of a ApoC fraction eluted from a DEAE-cellulose column. Elution profile 
(pattern a) and the analytical PAGE of corresponding fractions (pattern 
b). Both systems were run with 7% acrylamide in 8 M urea. Numbers (pat­
tern b) correspond to tube numbers of preparative elution profile.
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Figure 26. Basic PAGE of purified ApoC polypeptides. PAGE was run in 7% acrylamide in 8 M 
urea and stained with Coomassie Brilliant Blue. V = VLDL.
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Figure 27. Immunoelectrophoresis in IZ agar gel of ApoC poly-
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Figure 28. Basic PAGE of C-II polypeptides. PAGE was run in 
7% acrylamide in 8 M urea and stained with Coomassie Brilliant Blue.
V = VLDL.
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The group of C-I polypeptides present in the first fraction 
eluted from the DEAE-cellulose column (Fig. 23) was resolved by disc gel 
electrophoresis into three slow-moving bands (Figs. 24, 26). Examination 
of C-I by the acidic disc gel electrophoresis revealed three major fast- 
moving bands (Fig. 29) accompanied in some ApoC preparations from chyle, 
plasma VLDL, and HDL by two minor slow-moving bands. In a fortuitious 
experiment on acidic preparative disc gel electrophoresis, two of the 
major components were separated (Fig. 30), which indicated that at least 
two of these forms were stable. Another experiment on analytical disc 
gel utilizing the acidic system demonstrated that the three major bands 
isolated from VLDL were iramunochemically identical as indicated by the 
lines of fusion with various antisera (Fig. 31). On agarose embedding, 
the three bands had mobilities inversely related to those observed on 
the acidic polyacrylamide (Fig. 31).
With the availability of more specific antisera, it was found 
that the purified ApoC polypeptides reacted only with antisera which had 
specificity for ApoC or its various polypeptides. By direct comparison 
C-llI-0, C-III-1, and C-IIl-2 gave a complete fusion of immunoprecLpitin 
lines (Fig. 32a). On immunoelectrophoresis, reaction between ApoC and 
A-C-III resulted in a single precipitin arc while a reaction between the 
combination of C-III-1, C-lIl-2 and C-IIl-3, and A-C-III gave two precip­
itin arcs (Fig. 32b). These results indicated that C-III-3 might pos­
sibly have another or a different antigenic component. Direct compari­
sons of C-I and C-II, and of C-I and C-III showed non-identity of their 
immunoprecipitin lines (Fig. 33). Partial or non-identity of C-III and 
C-II was not demonstrated.
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Figure 29. Acidic PAGE of C-I polypeptides from various sources. PAGE was run in 7% acryl­
amide in 8 M urea and stained with Coomassie Brilliant Blue. 1 = ApoC from VLDL, 2 = C-I from VLDL,
3 = C-I from HDL, and 4 = C-I from chyle.
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Figure 30. Acidic PAGE of C-I polypeptides. PAGE was run in 
7% acrylamide in 8 M urea and stained with Coomassie Brilliant Blue.
V = C-I from VLDL,
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Figure 31. Immunoelectrophoresis and immunodiffusion of C-I-1, 
C-I-2 and C-I-3 polypeptides separated by 7% acidic PAGE. The C-I bands 
from acrylamide gel were embedded in 1 % agarose gels.
c-ffl-3
anti-C-ffl
C-ffl-2 
C-ffl-l 
C-ffl-0
anti-C-ffl
C-ffl-l,2,3
ro
Figure 32. Immunodiffusion and immunoelectrophoresis of C-III polypeptides. Anti-C-III added
to central well (pattern a). Purified C-III-1, C-III-2, and C-III-3 polypeptides were added to same 
well (pattern b).
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Figure 33. Comparison of C-I, C-II and C-III polypeptides by 
double diffusion. Anti-LP-C was added to central well.
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Partial Characterization of the Various 
Polypeptides of Apolipoprotein C
Amino Acid Composition 
Amino acid analyses of C-I, C-II, and C-III demonstrated that 
the polypeptides of ApoC isolated from VLDL have different amino acid 
compositions (Table 19). A characteristic feature of the amino acid com­
position of C-I was the absence of histidine, tyrosine, cystine, and 
cysteine. The amino acid composition of the C-II polypeptide showed that 
all amino acids were present. All of the C-III polypeptides isolated 
from VLDL had essentially no isoleucine with the exception of C-III-0.
The ApoC polypeptides, with the exception of C-II, were characterized by 
the absence of cystine and cysteine as determined by performic acid oxi­
dation.
Terminal Amino Acids 
Qualitative examination of ApoC polypeptides by dansylation 
demonstrated that serine was the N-terminal amino acid for C-III-1 
through C-III-3 and threonine for C-I and C-II. Trace amounts of serine 
and aspartic acid were present in one C-I preparation, while minor amounts 
of serine and glutamic acid were found in two C-II fractions.
Serine and threonine were also shown to be the N-terminal amino 
acids for ApoC isolated from LF-X.
Alanine was identified by kinetic studies with carboxypeptidase 
A as the carboxyl-terminal amino acid for all C-III polypeptides (0-4) 
isolated from VLDL. Valine was the only other amino acid released from 
these polypeptides. The C-III-1 and C-III-2 isolated from chyle and 
plasma HDL also had alanine as the C-termlnal amino acid. There was no
TABLE 19
AMINO ACID COMPOSITION OF ApoC POLYPEPTIDES ISOLATED FROM PLASMA VLDL
(M/105 g)
Amino Acid
Polypeptide
C-I C-II C-III-0 C-III-1 C-III-2 C-III-3 C-III-4
Lysine 88.46 51,85 61.42 55.48 52.81 52.80 44.07
Histidine - 3.32 7.26 1 0 . 8 6 8.03 4.67 13.88
Arginine 34.40 14.84 20.89 15.30 14.51 17.28 20.37
Aspartic Acid 65.74 62.23 62.60 71.06 71.39 8 6 . 2 0 74.68
Threonine 36.40 47.79 54.43 48.12 49.92 54.77 48.16
Serine 89.17 100.56 109.22 99.52 98.50 116.47 101.64
Glutamic Acid 129.88 121.23 118.11 114.08 113.96 126.58 120.13
Proline 17.84 42.85 22.72 26.78 29.10 37.70 29.18
Glycine 27.74 85.07 N.D.a 31.38 32.45 51.84 77.10
Alanine 52.53 82.42 85.65 1 0 0 . 0 0 101.08 98.00 104.99
Half Cystine^ - 5.99 - - - - -
Valine 27.96 42.22 43.18 59.17 61.22 52.88 63.23
Methionine 7.85 10.30 10.23 15.46 15.92 7.92 14.32
Isoleucine 34.46 9.70 5.72 - - - -
Leucine 82.62 51.94 49.92 49.15 48.40 47.44 48.33
Tyrosine - 18.89 23.70 18.73 18.63 14.47 17.01
Phenylalanine 39.78 31.31 27.82 38.10 39.71 39.40 38.48
Tryptophan 8.61 N.D.a N.D.a 25.65 28.11 N.D.a N.D.a
N3
Ln
Not determ ined*
Determined as cvsteic acid.
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release of carboxyl terminal amino acids from C-I or C-II polypeptides
treated with either carboxypeptidase A or B.
A forty-hour hydrazinolysis of ApoC from VLDL resulted in re­
lease of the following amino acids (pM/mg'lO ^): alanine (2.08), glycine
(1.54), aspartic acid (1.15), leucine (0.98), and glutamic acid (0.75). 
That alanine was released in this experiment from the C-III polypeptides
was confirmed by the hydrazinolysis of C-III which yielded alanine 
_2
(3.24 pM/mg'lO ) as the carboxyl terminal amino acid. No unequivocal 
results were obtained when C-I and C-II were examined by hydrazinolysis. 
The previous report (124) indicating valine as the C-terminal amino acid
of C-I could not be confirmed.
Carbohydrate Analyses 
There was some variability in the content of sialic acid among 
various C-III polypeptides. The C-III-0 had none, and C-III-2 contained
two moles of sialic acid/mole of peptide; both C-III-1 and C-III-3 had
one mole of sialic acid/mole peptide. The analysis of sugars and hexo- 
samines showed that both C-III-1 and C-III-2 had two moles of galactose 
and one mole of galactosamlne per mole of peptide.
The carbohydrate composition of C-I polypeptide was character­
ized by 6 -8 % glucose and small quantities of mannose and galactose 
(Table 20). The presence of glucosamine was observed in some C-I prep­
arations, but it was not calculable; galactosamlne was not determined.
No sialic acid was found in C-I.
Molecular Weight Determination 
The polyacrylamide SDS procedure showed that C-II and C-III
TABLE 20
CARBOHYDRATE COMPOSITION OF ApoC POLYPEPTIDES
Mannose Galactose Glucose Glucosamine Galactosamlne Sialic acid
Polypeptide
% Mole/Mole^ %
Mole/
Mble*
%
Mole/
Mole^ %
Mole/
MoleS %
Mole/
Mole*
%
Mole/
Mole*
C-I 0.71 0.29 0.84 0.34 8.04 3.30 Trace Trace N.D.'* N.D. - -
C-III-0 N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. - -
C-III-I - - 4.12 2.29 - - - - 1.33 0.70 2.68 0.88
C-III-2 - - 3.22 2.03 - - - - 1.99 1.04 4.87 1.645
C-III-3 N.D. N.D. N.D. N.D. N.D. N.D. - - N.D. N.D. 0.97
C-III-4 N.D. N.D. N.D. N.D. N.D. N.D. - - Trace Trace N.D. N.D.
Mole of carbohydrate/Mole of peptide.
Not determined.
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polypeptides had similar molecular weights. The molecular weight of C-I 
was lower than those of C-II and C-III. Minimal molecular weights of 
ApoC polypeptides calculated from the amino acid composition were in 
agreement with the values found by the polyacrylamide-SDS gel electro­
phoresis.
Table 21 summarizes the characteristics of the ApoC polypeptides.
Study on Immunochemical Properties and 
Polypeptide Composition of LP-X
Plasma samples from patients with obstructive jaundice contain 
the abnormal lipoprotein X (LP-X) which moves on agar electrophoresis 
towards the cathode and gives a precipitin arc with A-C-I but not with 
A-C-III (Fig. 34a,b); some plasma samples, however, show in the anodal 
compartment the characteristic LP-C precipitin arc (Fig. 34b). Since 
unabsorbed antisera to LP-X react with C-III polypeptide and since pdLP-X 
displays on polyacrylamide gels bands characteristic of C-III-1 and 
C-III-2, these results suggest that in LP-X the C-III peptides are im- 
munochemically buried while the C-I antigenic component is exposed.
On agarose immunoelectrophoresis the LP-X moves towards the 
anode (Fig. 34c). Plasma samples containing LP-X gave three precipitin 
lines with A-VLDL (Fig. 34d). Since the slower moving component with a 
mobility similar to that of LP-X showed a non-identity reaction with the 
second arc typical of LP-B, it was considered, indeed, to be due to LP-X. 
The similarity in the mobility of faster moving arc with that of C-III 
suggested that this arc represented the LP-C. These findings were sup­
ported by the fact that the A-VLDL reacted with C-I, C-III, and LP-B.
It has been demonstrated by Seidel e^ (96) that partially
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TABLE 21
SOME PHYSICAL AND CHEMICAL PROPERTIES OF 
APOLIPOPROTEIN C POLYPEPTIDES
Poly­
peptide
Carboxyl
terminal
Amino
terminal
Amino acid deletion
C-I - Threonine Cystine, cysteine, tyrosine 
and histidine
C-II - Threonine None
C-III-0 Alanine N.D. Cystine
C-III-1 Alanine Serine Cystine, cysteine and iso­
leucine
C-III-2 Alanine Serine Cystine, cysteine and iso­
leucine
C-III-3 Alanine Serine Cystine, cysteine and iso­
leucine
C-III-4 Alanine N.D. Cystine, cysteine and iso­
leucine
^Neutral sugars and hexosamines were not determined.
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TABLE 21— Continued
Molecular
weight
Carbohydrate 
moles/mole peptide
Electrophoretic 
mobility on 
agar
Isoelectric
point
(pl)
7,400 3 moles glucose y > 6
10,500 N.D. 6 2 5.46
8,750 No sialic acid^ G2 -B1 5.39
10,650 1 mole sialic acid
2 moles galactose
1 mole galactosamlne
8 1 - 0 2 5.17
11,250 2 moles sialic acid 
2 moles galactose 
1 mole galactosamlne
0 2 4.93
11, 275 1 mole sialic acid* « 2 4.86
10.800 N.D. & 2 4.79
ab
anti-C-F
anti-C-in
B
anti-C-I
anti-VLDL 
anti-VLDL
Figure 34. Immunoelectrophoresis of obstructive jaundiced plasma. Pattern a and b were run on 
1% agar gels. Pattern c and d were run on 1% agarose gels. A = obstructive jaundiced plasma and B = 
normal fasting plasma.
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delipidized LP-X contained two protein components, i.e., albumin and 
partially delipidized LP-C. The partially delipidized LP-X gave no re­
action with A-LP-A or A-LP-B; however, the precipitin lines obtained with 
anti-albumin and A-VLDL showed a non-identity reaction. Also, two to 
three lines were observed with A-LP-C and A-VLDL. When albumin was sep­
arated by ultracentrifugation from pdLP-C following partial delipidiza- 
tion, the latter showed a disc gel pattern very similar to that of pdLP-C 
obtained from hyperlipemic VLDL. On direct comparison by double diffu­
sion, pdLP-C obtained from LP-X showed two lines of identity with pdLP-C 
from VLDL when it was reacted with A-LP-C and only one line of fusion 
when it was tested with A-VLDL.
CHAPTER V
DISCUSSION
The studies of the various density lipoprotein classes isolated 
from postprandial and fasting chyle, fasting normal plasma, random plasma, 
and hyperlipemic plasma have shown that each density class examined was 
heterogeneous with respect to its protein moieties. In fact, all density 
classes examined contained the three lipoproteins LP-A, LP-B, and LP-C 
in varying concentrations under one metabolic circumstance or another.
For example, LP-A was found to be present in postprandial chyle VLDL and 
essentially absent in normal fasting VLDL of plasma. The LP-B and LP-C 
were present in all VLDL samples examined except for one VLDL preparation 
that consisted only of LP-C. The VHDL represented the only exception to 
this general finding because they contained only LP-A. These results, 
supported by immunodiffusion, immunoelectrophoresis, and PAGE, are in 
agreement with previous observations on the protein heterogeneity of the 
various density classes (3, 83, 90, 96, 108, 109, 113).
Originally, ApoC was found only in the VLDL of hyperglyceridemic 
subjects (3) and postprandial VLDL chyle (108). Present studies have 
clearly established that LP-C occurs in all density classes of hypertrig- 
lyceridemic, as well as normal plasma and chyle. This is also supported 
by the recent findings of ApoC polypeptides in the various density classes
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(118-122). This accomplishment has been a result of refinements in tech­
niques, such as the introduction of disc gel electrophoresis for the rou­
tine identification of the acidic ApoC polypeptides and the availability 
of specific antisera.
Polyacrylamide gel electrophoresis (PAGE) studies indicated a 
relatively simple way to examine the lipoprotein composition of the var­
ious density classes. These studies have demonstrated that there are 
three principal regions on the 7% basic polyacrylamide separating gel 
that correspond to the three currently recognized lipoprotein families: 
LP-B occurring at the juncture of the stacking and separating gels, LP-A 
present in the intermediate region between the fast-moving bands, and a 
slower moving band in the LP-A region. Unfortunately, there are several 
difficulties associated with this system. Low concentrations of HDL must 
be utilized to visualize the bands associated with LP-A. At high concen­
tration where the LP-C bands can be most readily visualized, the LP-A 
bands are blurred and apparently have a tendency to aggregate. A second 
difficulty is that the C-I polypepHde(s) overlap(s) with the LP-A bands 
and cannot Le positively identified in the basic system. It is, there­
fore, necessary to run the acidic system in order to verify its presence. 
The correlation of the LP-A bands seen on PAGE with the known ApoA poly­
peptides and the characterization of several unknown bands in that re­
gion has not been shown in this study. Also, the detection of LP-B, LP-C, 
and, in some cases, LP-A in the loading and stacking gels has been indi­
cative of a probable association of lipoprotein families that cannot be 
separated by this technique. The possibility of denatured material in 
the loading, stacking, and juncture of the stacking and loading gels can­
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not be excluded and is always a potential problem in the evaluation of a 
PAGE gel pattern. In contrast to 7%, the 3% polyacrylamide gel electro­
phoresis was found to be completely unsatisfactory for identifying the 
lipoprotein families or the polypeptides associated with these families.
The pattern of the apolipoproteins on basic PAGE is similar to 
that observed with intact lipoproteins; and, again, if high concentra­
tions are utilized, the separation of ApoA is not sharp. A scheme pre­
senting the localization of various apoHDL and ApoC polypeptides is 
shown in Fig. 22. Identification of the ApoC polypeptides by analytical 
polyacrylamide gel electrophoresis has been found to be more reliable 
than immunochemical techniques. In addition, the analytical polyacryl­
amide gel electrophoresis, but not the immunological techniques, distin­
guishes the various polymorphic forms of polypeptides which have similar, 
if not identical, immunochemical properties.
Combining acrylamide electrophoresis and immunodiffusion to in­
vestigate normal fasting VLDL has demonstrated that some of the protein 
and lipid remains in the loading and stacking gels, while at least a por­
tion of the C-III polypeptides is readily dissociated. Seven percent 
basic acrylamide patterns have demonstrated that the C-III peptides can 
always be detected in the separating gel whether urea is present or not; 
the addition of urea has no apparent effect on the intensity of the C-III 
staining. In the absence of urea in the loading gel, the bands of C-I 
and C-II were either not present or present only in small amounts. Since 
C-II is dissociated and detected in the separating gel when urea is added 
to the loading gel, it seems that the C-II has a higher affinity for the 
VLDL molecule, or one of its components, than the C-III polypeptides.
136
C-I is occasionally seen on basic acrylamide but it can always be detected 
as a faint band(s) on acidic acrylamide. These studies have indicated 
that ApoC polypeptides dissociate from VLDL in the following order: 
C-III>C-II>C-I. This has been further supported by the immunological 
studies of VLDL which have indicated that the C-I is not dissociated from 
the VLDL molecule while C-III frequently is. In conclusion, the normal 
fasting VLDL molecule is a complex consisting of LP-B and LP-C with the 
C-III-1 and C-III-2 polypeptides being dissociated to some extent.
Paper and agarose electrophoretic results were of questionable 
value in determining the presence or absence of a particular lipoprotein 
family. The a 2-mobility of normal fasting VLDL was associated with LP-B 
and LP-C and not with LP-B and LP-A as previously reported (111, 112).
The lipoprotein with oj-mobility found after dissociation of VLDL is 
most likely due to pdLP-C (Fig. 17) and not pdLP-A since none, or very 
little, LP-A was immunochemically detectable in partially delipidized, 
normal fasting VLDL.
Examination of VLDL from chyle under various dietary conditions 
revealed the presence of LP-A, LP-B, and LP-C in agreement with previous 
reports (107, 108, 110). The principal difference between fasting plasma 
and postprandial chyle VLDL with respect to their apolipoproteins was the 
presence of ApoA in chyle VLDL. Although LP-B was not positively identi­
fied in the chyle > 400, its presence has been reported previously 
(107, 108); the occurrence of LP-B is further supported by the presence 
of some insoluble material in the totally delipidized lipoprotein frac­
tion with Sg > 5,000. In fact, the finding of approximately 80% LP-A by 
polyacrylamide gel electrophoresis of the postprandial chyle chylomicrons
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seems to indicate that ApoA is very important in the transport of exo- 
geneous triglycerides. The decrease in the relative LP-A concentration, 
with an accompanying increase in the relative LP-C concentration, in the 
chyle VLDL seen in the transition from a postprandial to a fasting state 
was suggestive of a selective removal or dissociation of LP-A from the 
chylomicron molecule yielding the postulated chylomicron remmants (164). 
In fact, since LP-A was found to be essentially absent from normal fast­
ing VLDL, it was hypothesized that the presence of LP-A in fasting plasma 
VLDL (S^ > 20) was indicative of a metabolic disorder or impairment as­
sociated with removal or dissociation of these molecules of exogeneous 
origin. This hypothesis was supported by the finding of LP-A in both 
type I and type V hypertriglyceridemic plasma, with both types being 
characterized by the presence of chylomicrons (51).
The immunochemical identification of A-I and A-II in the chyle 
chylomicrons supports the finding that ApoA is composed of these two non­
identical polypeptides (126, 130) and extends the reports of ApoA being 
associated with chylomicrons (107, 108).
Band G (Table 9) found in chylomicrons had a mobility on disc 
gel electrophoresis similar to that seen with purified plasma lipoprotein 
lipase (165). The mobility of band G was similar to that of A-I and al­
bumin, but since neither A-I nor albumin were identified immunochemically 
in the > 5,000, it is suggested that this band may be due to plasma 
lipoprotein lipase.
One site of biosynthesis of LP-A, LP-B, and LP-C is the liver, 
as demonstrated by a combination of radioisotope and immunochemical tech­
niques for LP-A and LP-B (166, 167), while the ApoC polypeptides have
138
boon identifit'cl in the Golgi apparatus isolated from rat liver (168). 
Ockner ^  aJL. identified immunochemlcally the presence of Id’-A in rat 
intestinal lymph; this supported earlier findings (171, 108), The bio­
synthesis of LP-B has been demonstrated in the intestine (169, 170). The 
large percent of ApoA found in thoracic chyle chylomicrons indirectly sup­
ports its biosynthesis in the intestine, even though the possibility ex­
ists that a portion is of plasma origin (172, 173). Identification of 
ApoC in thoracic lymph and the immunoprecipitin arc seen when mucosal 
scrapings were examined by double diffusion with A-LP-C are indications 
of the intestinal origin of ApoC. From these findings, and earlier re­
ports, it appears that all three lipoprotein families are synthesized in 
both the liver and the intestine.
Recent cooperative work with D. Ganesan e^ al^ . (174) on the ac­
tivation of heparin-released plasma lipoprotein lipase (LPL) from human, 
dog, and rat revealed that the ApoC polypeptide, C-I, gave the maximal 
activation of this purified enzyme while C-II activated lipoprotein lipase 
(LPL) to a lesser extent and C-III had no effect. Since these results 
were different from those reported previously (124, 125), studies on 
human and rat adipose tissue and cow and human milk LPL were carried out. 
In agreement with published reports, it was found that C-II activated the 
LPL from both adipose tissue and milk while C-III activated human milk 
LPL but had little effect on human adipose LPL (125). C-I had no effect 
on the activation of LPL of either adipose tissue or milk origin. This 
difference in the activation of plasma and tissue lipolytic activities 
has been interpreted as evidence for two different lipoprotein lipases. 
These findings also suggest that one of the biological functions of two
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ApoC polypeptides may be in the removal of triglycerides from the systemic 
circulation by activation of lipolytic enzymes- In fact, the suggestion 
that the underlying cause of hyperchylomicronemia (Type I) is a defective 
plasma LPL (175) has been supported in this study by finding that the 
purified heparin-released plasma LPL isolated from Type I was not acti­
vated by C-I but that there was some activation by C-II (174). It has 
been suggested, on the basis of this experiment, that two enzymes may be 
present in the systemic circulation.
These results seem to indicate that chylomicron catabolism is 
probably effected primarily by the heparin released LPL. The primary 
substrate for the adipose tissue lipase may be the very low density lipo­
proteins or, more specifically, the triglyceride-rich LP-A released from 
chylomicrons during catabolic reactions occurring either in the systemic 
circulation or at the surface of endothelial linings. It is possible 
that, in a synchronized mechanism, both enzymes act simultaneously on 
chylomicrons as well as on VLDL. Alternatively, plasma LPL might catab- 
olize the chylomicron triglyceride leaving the remmants as the substrate 
for the adipose tissue LPL. The latter hypothesis is favored.
To facilitate the study of lipoproteins, the production of anti­
sera was undertaken. The heterogeneity of the antisera produced by im­
munization with various density classes supported the protein heterogene­
ity detected in this study by disc gel and previously reported (3, 83,
90, 108). Results of this study have shown that it is very difficult to 
produce a specific antibody to one lipoprotein family by injecting a 
given density class. In fact, the injection of HDL^ results in the pro­
duction of A-LP-A, A-LP-C, and, usually, A-LP-B. A-HDL^ contained anti­
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body to LP-B, even though the original antigen contained no detectable 
LP-B by double diffusion. This phenomenon may be explained by the fact 
that the LP-B is easily denatured and is probably adsorbed on the lipo­
proteins to be injected. Since LP-B is a good antigen, and denatured 
material is even Lecter (176), antibody to LP-B is commonly obtained. 
Identification of LP-A in a fasting "normal" VLDL with A-HDL^ is most 
likely due to LP-C and not LP-A. It is possible that the earlier reports 
of LP-A being present in normal fasting VLDL (111, 112) either reflects 
the identification of LP-C or suggests that the designation of subjects 
as normal is questionable. Injection of normal fasting VLDL as antigen 
resulted in antisera with specificity for both LP-C and LP-B while the 
injection of LDL usually gave antisera specific for LP-B.
Injection of individual polypeptides resulted in the preparation 
of specific antisera. The immunoelectrophoretic pattern of whole plasma 
tested with some of these antisera illustrates (Fig. 35) the complexity 
of lipoproteins found in normal plasma.
Whereas LP-X and LP-B families can be readily identified, the 
patterns of LP-A and LP-C families are somewhat more complex. Two immuno­
precipitin arcs formed with A-LP-A and its two polypeptides indicate the 
probability of two lipoproteins carrying the LP-A antigenic components, 
one of which is associated with A-I and A-II and the other associated 
only with A-I. This interpretation is supported by the finding of only 
A-I in a lipoprotein isolated from HDL^, while A-I and A-II were found 
to be associated together in the HDL^ (177). Two forms of LP-A have been 
recently identified (178); one contained only A-I and the other both A-I 
and A-II.
AGAROSE LP-X LP-B VLDL(LP-B, LP-C)
LP-A-LDLP-A-I LP-C
AGAR LP-X LP-B VLDL(LP-B, LP-C)
LP-A-ILP-C LP-A-LD
Figure 35. Schematic presentation of immunoelectrophoretic patterns of lipoprotein families in 
whole plasma.
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The antigenic complexity of ApoC was supported by the production 
of antisera to ApoC and LP-X. A minimum of three antigenic components 
were identified in association with ApoC: C-I, C-II, and C-III-0, 1, 2.
From these studies it was concluded that the polypeptides C-I, C-II, and 
C-III are antigenically distinct. Further evidence for this conclusion 
was obtained from results of studies on the amino acid composition, ter­
minal, amino acids, and electrophoretic behavior. Two additional anti­
genic components may exist, one of which may be associated with C-III-3. 
The other, detected with A-C-I^y, may be due to the aggregation of C-I 
with some other polypeptide or protein, such as albumin, or may represent 
an unknown haptenic substance such as that reported by Beaumont and 
Baud’t (179). In normal whole plasma two types of LP-C lipoproteins are 
visualized on immunoelectrophoresis: one is present as an association 
with LP-B in the VLDL complex, whereas the other is apparently a free 
LP-C. At the present time it is not possible to conclude whether the 
unassociated LP-C found in HDL represents an entity consisting of all 
three ApoC antigenic components or a dissociated LP-C.
The detection of antibodies to albumin in the C-I antiserum was 
surprising since albumin should have been removed by exclusion on Sepha- 
dex G-75 or by DEAE-cellulose chromatography in 8 M urea. From this 
finding it was concluded that albumin has an affinity for the C-I poly­
peptide.
Attempts to separate LP-C from either VLDL or from other density 
classes were unsuccessful utilizing several different approaches, with 
the exception of hydroxylapatite column chromatography. The latter was 
not successful, but it was promising. Apparently, the most promising
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procedure to isolate LP-C as a lipoprotein is by immunoprécipitation of 
LP-B and LP-A from HDL or LDL^.
The results of successful isolation and characterization of 
pdLP-C were in agreement with those previously reported by Gustafson 
et al. (3). Serine and threonine were found to be the N-terminal amino 
acids for both plasma and chyle pdLP-C, and a sedimenting peak with an 
®w 20 approximately 7S was obtained with pdLP-C from both sources. 
PdLP-C was also found to be immunochemlcally distinct from LP-A and LP-B. 
From these data it has been concluded that this partially delipidized 
lipoprotein corresponds to the lipoprotein previously designated as LP-C. 
Separation on disc gel, DEAE-cellulose chromatography, and the immuno­
chemical results have established clearly that the protein moiety of 
pdLP-C consists of C-I, C-II, and C-III.
Although Brown (118) claimed not to be able to reproduce
the ultracentrifugal method, this procedure was reproduced rather con­
sistently in our hands. However, this isolation procedure was abandoned 
because it had resulted in a low yield of ApoC (10% ApoC from the total 
protein in VLDL).
Examination of the non-albumin protein portion of LP-X by poly­
acrylamide gel electrophoresis and immunodiffusion revealed that its 
polypeptide composition was very similar, if not identical, to that of 
pdLP-C from VLDL, as reported previously (180). The terminal amino acids 
were essentially the same as determined by dansylation, hydrazinolysis, 
and carboxypeptidase analysis (163). The fact that the antisera produced 
with LP-X reacted with C-I, C-II, and C-III was also a strong indication 
that the principal polypeptides of ApoC from VLDL and dealbuminated ApoX
144
were the same. The possible difference between the ApoC preparations 
from LP-X and LP-C was in the ratio of C-III-1 to C-III-2 polypeptides; 
this ratio was greater than one for ApoC from VLDL whereas it was less 
than one for ApoC from LP-X. The ratio of C-III polypeptides of LP-X is 
similar to that of ApoC isolated from thoracic duct chyle. The signifi­
cance of the C-III-1 to C-llI-2 ratio is not known, but it may reflect 
the differences in origin or metabolism of these polypeptides. It is 
interesting to note that LP-C of individuals with the genetic disorder 
abetaproteinemia consists of C-I, C-II, and C-III-2, but not C-III-1 
(181). These findings may indicate either a possible difference in tis­
sue origin of C-III-1 and C-III-2 or a possible block in the interconver­
sion of C-III-2 to C-III-1 in abetaproteinemic subjects.
In contrast to the 50% recovery of ApoC reported by Brown e^ al. 
(118), the yield of ApoC never exceeded 35% in the present study. The 
former finding is in variance not only with results of Gustafson ei[ al.
(3) but also with figures from these studies. It has been concluded that 
the percentage of ApoC is not a constant value but that it depends upon 
the particular metabolic state of an individual, and then it can be in­
fluenced by the dietary regimens and other unknown metabolic factors.
The fractionation of ApoC resulted in the isolation of four major 
polypeptides. The amino acid composition of these four polypeptides was 
similar to that reported previously (120) with the exception of the poly­
peptide designated C-II which was found to contain both histidine and 
cysteic acid. The detection of threonine as the N-terminal amino acid 
of C-I and C-II and serine as the N-terminal amino acid of C-III was in 
full agreement with some results reported by Brown e^ (120). No
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valine, however, was released from C-I by hydrazinolysis or carboxypep­
tidase. Only alanine was identified as carboxyl terminal for the C-lII 
polypeptides.
The molecular weights and the sialic acid content of C-III-1 
and C-III-2 were in good agreement with those reported previously (120). 
Carbohydrate analysis of C-III-1 and C-III-2 revealed 1 mole of galact- 
osamine and 2 moles of galactose for each polypeptide. The only differ­
ence noted between these polypeptides was the difference in sialic acid 
content.
The high percent of glucose and trace amounts of mannose and 
galactose found in several preparations of C-I might account lor some of 
the heterogeneity of these particular polypeptide preparations.
From the similarities in amino acid deletions, PAGE patterns, 
immunoelectrophoretic mobility, N-terminal analyses, and molecular 
weights, it has been concluded that the polypeptides isolated by Brown
(118-120) and the C-I, C-II, and C-III-1, 2 polypeptides isolated 
from ApoC are identical.
Results of the present study, however, extended these findings 
by identifying several polymorphic forms of C-I and C-III polypeptides. 
Since the three major bands of C-I were immunologically identical, it has 
been assumed that certain major characteristics of these three polymorphic 
forms must be similar. Although two of these forms were isolated, the 
quantities were not sufficient for a detailed characterization. Since 
all three forms of C-I were immunochemically identical, but different in 
electrophoretic mobility, the microheterogeneity could be due to either 
a difference in the carbohydrate content or traces of albumin. Other
146
possible reasons for this microheterogeneity (182) include differences 
in tissue origin, artifacts arising from the isolation procedures, con- 
formers (183), differences due to action of peptidase, amino acid re­
placements, or amide nitrogen.
The detection of five polymorphic forms of C-III is another ex­
ample of polypeptide microheterogeneity. Differences between C-III-1 
and C-IIl-2 observed on disc gel electrophoresis have already been shown 
to be due to the difference in sialic acid content (120) which probably 
also accounts for the observed mobility of C-III-0. The cause of hetero­
geneity in C-III-3 and C-IlI-4 is not known; the C-III-3 polypeptide con­
tained one, rather than three moles of sialic acid.
The C-II polypeptide may also be polymorphic since, in some 
samples, a minor band was found adjacent to the principal band. The C-II 
polypeptide was usually recovered in a yield lower than that expected 
from its estimated content determined by densitometric scanning of poly­
acrylamide gels. It appears that C-II may be lost during the purifica­
tion procedure. Additional studies on its chemical and physical charac­
teristics are necessary to resolve the differences between data obtained 
in this study and those reported by Brown et (120).
The column chromatographic elution patterns, electrophoretic 
behavior, and immunological properties of ApoC isolated from various 
sources such as plasma and chyle VLDL, plasma HDL, and LP-X indicate that 
its qualitative polypeptide composition is similar, if not identical.
The possible differences in the stoichiometric proportions of polypep­
tides in these ApoC preparations may be due to the tissue origin, inter- 
conversion of polymorphic forms, differential removal rates, or a general
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or specific derangement of lipid transport processes.
In contrast to the view that each ApoC polypeptide forms Its 
own lipoprotein (118), results of this study suggest an association of 
C-I, C-II, and C-III in a lipoprotein designated as LP-C. The evidence 
for this association is based on the following observations: 1) the par­
tially delipidized LP-C isolated from chyle and plasma VLDL behaved as a 
chemical entity and contained only C-I, C-II, and C-III; 2) the protein 
moiety of an abnormal low-density lipoprotein, LP-X, consisted of C-I, 
C-II, C-III and albumin; after partial delipidization, albumin could be 
removed from a phospholipid-protein residue which still contained C-I, 
C-II, and C-III as its constitutive polypeptides; 3) purified post-heparin 
lipoprotein lipase was found to be associated only with C-I, C-II, and 
C-III.
It is hoped that the utilization of monospecific antibodies may 
provide an unequivocal answer to the question whether ApoC-polypeptides 
are constitutive polypeptides of ApoC or separate apolipoproteins.
CHAPTER VI
SUMMARY
All ultracentrifugally Isolated density lipoprotein classes from 
chyle and from normal and hypertriglyceridemic plasma samples were found 
to be heterogeneous with respect to their apolipoprotein moieties. The 
distribution of apolipoprotein C was expanded to include all the ultra­
centrifugally defined density classes with the possible exception of the
1.21 infranate.
Three regions on 7% polyacrylamide gels have been correlated 
with the currently recognized lipoprotein families: LP-A, LP-B, and
LP-C. Utilization of both acidic and basic polyacrylamide gel electro­
phoresis in 8 M urea resulted in the identification of C-1, C-11, and 
C-Ill polypeptides, both in their intact or totally delipidized form.
Based on immunodiffusion patterns and polyacrylamide gel elec­
trophoresis data, it was concluded that normal, fasting VLDL is a complex 
consisting of LP-B and LP-C. The C-IIl-1 and C-111-2 polypeptides were 
found to be dissociated to some extent from the VLDL by polyacrylamide 
gel electrophoresis and immunoelectrophoresis.
Examination of thoracic duct chyle confirmed the presence of 
LP-A and LP-C in chyle chylomicrons and extended these observations by 
the immunochemical identification of A-I and A-11.
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Antisera to the three lipoprotein families and their major poly­
peptides were prepared. These antisera had specificity for LP-A, LP-B, 
LP-C, A-I, C-I, C-II, and C-III.
Two procedures were developed to isolate partially delipidized 
LP-C. Both procedures were based on partial delipidization of hypertri­
glyceridemic VLDL followed by ultracentrifugation or immunoprécipitation 
to remove pdLP-A and pdLP-B. Characteristics of the pdLP-C isolated by 
ultracentrifugation or immunoprécipitation were identical to those of 
the pdLP-C described by Gustafson et al. (3). Furthermore, pdLP-C con­
tained C-I, C-II, and C-III polypeptides. In addition, C-III-1 and 
C-III-2 were positively identified in pdLP-C.
Apolipoprotein C and its polypeptides were isolated by a proced­
ure consisting of gel filtration, DEAE-cellulose chromatography, and prep­
arative polyacrylamide gel electrophoresis. Three groups of polypeptides, 
C-1, C-II, and C-III, were isolated and partially characterized. From 
these data it was concluded that C-I, C-II, C-III-1, and C-III-2 corre­
spond to the polypeptides described previously by Brown ^  (118-120).
Several polymorphic forms of C-I and C-III were identified and 
designated as C-I-1, C-I-2, C-I-3, C-III-0, C-III-1, C-III-2, C-III-3, 
and C-III-4. The polymorphism of C-III-0, C-III-1, and C-III-2 was ap­
parently due to variations in the content of sialic acid, while that of 
the other polypeptides has not yet been explained since C-I-1, C-I-2, 
and C-I-3 do not contain sialic acid and C-III-3 contains the same amount 
of sialic acid as C-III-1.
Lipoprotein C was not isolated in its intact form. However, the 
isolation of pdLP-C and the presence of only pdLP-C and albumin in pdLP-X 
indirectly support the existence of a lipoprotein designated as LP-C.
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APPENDIX
NOMENCLATURE AND ABBREVIATIONS OF LIPOPROTEINS
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161
Operational Nomenclature of Lipoproteins 
VLDL Very low-density lipoproteins, lipoproteins of d < 1.006 g/ml
and Sg > 20; ag-LP, pre-g-LP, lipoproteins displaying the elec­
trophoretic mobility of a^-globulins.
LDL Low-density lipoproteins, lipoproteins of d 1.006-1.063 g/ml and
0-20; g^-LP, g-LP, lipoproteins displaying the electrophoretic 
mobility of g^-globulins.
LDL^ Subfraction of low-density lipoproteins of d 1.006-1.019 g/ml.
LDLg Subfraction of low-density lipoproteins of d 1.019-1.063 g/ml.
HDL High-density lipoproteins, lipoproteins of d 1.063-1.210 g/ml;
a^-LP, a-LP, lipoproteins displaying the electrophoretic mobil­
ity of a^-globulins.
HDLg Subfraction of high-density lipoproteins of d 1.063-1.125 g/ml.
HDLg Subfraction of high-density lipoproteins of d 1.125-1.210 g/ml.
VHDL Very high-density lipoproteins, lipoproteins of d > 1.210 g/ml.
VHDL^ Very high-density lipoproteins, lipoproteins of d 1.210-1.250
g/ml.
VHDL2 Very high-density lipoproteins, lipoproteins of d  ^ 1.250 g/ml.
Chemical Nomenclature of Lipoproteins
LP-A Lipoproteins containing apolipoprotein A.
LP-B Lipoproteins containing apolipoprotein B.
LP-C Lipoproteins containing apolipoprotein C.
LP-X Abnormal low-density lipoprotein characterizing obstructive
jaundice. Protein moiety consists of apolipoprotein C and al­
bumin.
Ibl
Abbreviations o£ Lipoproteins 
a-LP Alpha-lipoproteins 
a^-LP Alpha^-llpoprotelns 
Og-LP Alpha^-lipoproteins 
ApoA Apolipoprotein A
ApoB Apolipoprotein B
ApoC Apolipoprotein C
apoHDL Totally delipidized high-density lipoproteins
apoHDLg Totally delipidized subfraction of high-density lipoproteins
apoVLDL Totally delipidized very low-density lipoproteins
ApoX Apolipoprotein X
g-LP Beta-lipoproteins
g^-LP Beta^-lipoproteins
pdLP-A Partially delipidized lipoprotein A
pdLP-B Partially delipidized lipoprotein B
pdLP-C Partially delipidized lipoprotein C
pdLP-X Partially delipidized lipoprotein X
pdVLDL Partially delipidized very low-density lipoproteins
Abbreviations
A-LP-A,
A-C-I,
etc. A - • antisera with specificity for the designated antigenic
component(s)
A-WS Anti human whole serum
C Cholesterol
CPA Carboxypeptidase A
CPB Carboxypeptidase B
lb)
d
d
d:;a k
di-DNP
EDTA
g
g-min
LPL
N.D.
PL
PAGE
rpm
S
®20,w
®20,w
SDS
Sf
TEMED
TO
Tris
TCA
Isolation density of lipoproteins 
Hydrated density of lipoproteins 
Diethylami noethyl 
Di-dinitrofluorobenzene 
(Ethylenedinitrilo)tetraacetic acid 
Gravity units
Product of gravity units and minutes, "centrifugal force" 
Lipoprotein lipase 
Not determined 
Phospholipids
Polyacrylamide gel electrophoresis
Revolutions per minute
Observed sedimentation coefficient
Observed sedimentation coefficient in water at 20°C
Sedimentation coefficient at infinite dilution in water at 20°C
Sodium dodecyl sulfate
Flotation coefficient in a NaCl solution of density 1.063 g/ml
N,N,N' ,N'-tetraiüethylethylene diamine
Triglycerides
2-amino-2(hydroxymethyl)- 3-propanediol 
Trichloroacetic acid
